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ABSTRACT 
Despite nearly 25 years of research, pathogenesis of fetal death in PRRS still remains unclear. 
This large-scale study is aimed to provide overarching insight into the process of infection within 
uterus and fetus. Hypotheses of this thesis are that PRRSV-specific pathological lesions, their 
severity, replication in susceptible cells, and cell death are significantly associated with PRRSV 
infection both on maternal and fetal side, and fetal death. The objectives of this thesis were to 
assess potential associations between specific histopathological lesions, numbers of CD163, 
CD169, apoptotic cells and areolae at the maternal-fetal interface (MFI) and PRRSV RNA 
concentration in the fetuses and the MFI. Dams and their litters were humanely euthanized and 
necropsied 21 days later. Samples from the maternal-fetal interface (uterus with fully attached 
placenta) and fetal thymus were collected for analysis by RT-qPCR to quantify PRRSV RNA 
concentration. The corresponding paraffin-embedded uterine section was subjected to 
immunohistochemistry for PRRSV nucleocapsid N protein, CD163, CD169, cathepsin and 
TUNEL assay for apoptosis. Our findings confirm type 2 PRRSV infection in pregnant gilts 
induces significant histopathological lesions at MFI, but they are not associated with the 
presence of PRRSV in the MFI and fetal thymus at 21 days post infection. Fetal pathological 
lesions are associated with the presence of PRRSV in the MFI and fetal thymus, and meconium 
staining of fetuses is significantly associated with the presence of both fetal and umbilical lesions 
observed 21 days post infection. Studies presented in this thesis confirm that although type 2 
PRRSV infection in pregnant gilts in the third trimester of gestation induces significant 
pathological lesions at the maternal-fetal interface, fetal and umbilical pathology together with 
PRRSV viral load in the fetus and increased cell death at the MFI contribute to fetal compromise 
and death. This study also found that only an increase in numbers of CD163 positive 
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macrophages in the endometrium in concert with the decrease in the numbers of CD163 positive 
macrophages in the fetal placenta significantly increased the probability of PRRSV infection of 
the fetus. 
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1 LITERATURE REVIEW 
1.1 Female reproduction of swine 
1.1.1 Normal reproductive cycle and gestational physiology 
Pigs are polytocous species of domestic animals, which means that, in a reproductive 
cycle, can give birth to a larger number of offspring (piglets), which, in modern swine production 
is typical between 10 and 16 piglets (Soede 2011). The ovarian activity of pigs is cyclical during 
the whole year and manifested by 18-25 day long estrus cycle with ovulation happening 
approximately 44 hours after the onset of the luteinizing hormone (LH) peak (Soede 2011). In 
pigs, sexual maturity (puberty) is reached between 150 and 220 days of age and the gestation 
lasts an average of 114 days (Senger 2012). Pregnancy is a complex physiological process in 
which the whole body (and particularly reproductive organs) undergo numerous morphological, 
histological, and hormonal changes which are a direct consequence of growth and development 
of the conceptus and strong maternal organ responses (Senger 2012).  
The success of the pregnancy depends on proper attaching of the embryo to the uterus 
epithelium in the four-step process comprised of the development of the embryo, hatching of the 
blastocyst, maternal recognition of gestation and formation of extraembryonic membranes 
(placenta) (Bazer and Johnson 2014). The unique property of gilts and sows in comparison to 
other mammalian species is the ability of pig fetus to produce estradiol as a signal for maternal 
recognition of pregnancy (Bazer 2013). 
Another specificity of pig gestational physiology is the secretion of PGF2α under the 
influence of estradiol which is rerouted from the uterine endometrial vasculature into the uterine 
lumen preventing the luteolysis of the corpus luteum which secretes sufficient amounts of 
progesterone and termination of the pregnancy (Bazer 2013). Porcine fetuses also produce PGE2 
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to stimulate contractions of the uterine myometrium which has the goal to distribute fetuses 
equally in the uterine horns attaining at least two fetuses per uterine horn (Senger 2012). 
Conversely, PGE2 will be secreted to the endometrial vasculature and cause luteolysis (Senger 
2012). In comparison to other species, the pig placenta do not produce progesterone but secrete 
the relaxin and estrogen which are essential for initiation and facilitation of the parturition (Bazer 
2009). 
1.1.2 Placentation  
In pigs, the placenta is diffuse epitheliochorial type characterized by direct attachment of 
intact uterine epithelium and placental trophectoderm during whole pregnancy (Friess 1981). 
Through the attachment of these epithelial cells, maternal hematotroph and histotroph provide 
the metabolites for the development and growth of the fetus (Bazer and Johnson 2014). 
Furthermore, chorionic folds and endometrial folds form invaginations that increase the area and 
size of uterine-placental attachment and reduces the distance between maternal and fetal blood 
creating short diffusion distances for nutrients (Enders and Blankenship 1999). In addition to the 
extensive interdigitation of microvilli on the trophectoderm and uterine epithelium, there are also 
specialized structures called areolae that support the fetus (Friess 1981). These are dome-shaped 
structures that form at the openings of uterine glands, where the trophectoderm, and then 
chorion, never fuses with uterine epithelium (Friess 1981). In the areolae, secretions from 
superficial and deep uterine glandular epithelium together with selective transudation from 
maternal serum create histotroph which is absorbed by fluid phase pinocytosis into tall columnar 
cells of chorionic epithelium and further released into the placental capillaries and fetal 
circulation (Bazer and Johnson 2014). This mechanism is similar to the absorption of 
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immunoglobulins in colostrum across the gut and directly into the blood of neonatal mammals 
(Bazer and Johnson 2014).  
The histotroph contains many essential molecules necessary for the development of the 
fetus, such as uteroferrin, plasmin/trypsin inhibitor, lysozyme, hexosaminidase, phospholipases, 
prostaglandin synthases, insulin-like growth factors 1 and 2, glucose, amino acids, 
prostaglandins, calcium, sodium, potassium, and some hormones (Bazer 2009). Uteroferrin is 
known to have an essential role in the transport of the iron to the fetus for the synthesis of 
hemoglobin (Saunders 1985). A significant correlation exists between porcine fetal weight and 
placental length, placental surface area, and total areolae surface area per placenta suggesting the 
importance of areolae in the development of the fetus (Knight 1977). During gestation, a fully 
functional placenta supporting the fetus with the adequate placental surface area and numbers of 
areolae (e.g. 2500) are formed by 60 to 70 days (Knight 1977). In the reproductive form of 
PRRS, associated lesions are frequently located in the uterus and placenta of pregnant gilts and 
sows, both in cases of natural and experimental PRRSV infection (Christianson 1993; Lager and 
Halbur 1996). 
1.1.3 Cathepsin 
Cathepsins are a group of serine proteases present in the lysosomes of cells (Turk 2012). 
Due to their importance in the terminal degradation of protein in the lysosomes, they play 
numerous roles in physiological processes such as angiogenesis, apoptosis, and remodeling of 
the tissue (Turk 2012). In mammalian species, epithelium of the endometrium, placental areolae, 
and fetal intestine are confirmed to express cathepsins B and L (Salamonsen and Nie 2002). The 
role of cathepsins in the remodeling of endometrial and placental tissues is to reduce the distance 
between maternal and fetal blood vessels, and in that way enhance transplacental transport of 
 4 
gasses and nutrients required for the development of the fetus (Salamonsen and Nie 2002). In 
pigs, cathepsin L1 is particularly highly expressed during gestation in the chorionic epithelium 
that forms areolae (Song 2010). 
1.2 Overview of PRRS 
1.2.1 Disease background and impact  
When porcine reproductive and respiratory syndrome (PRRS) was initially named 
“Mystery Swine Disease,” in the late ninteen-eighties after several catastrophic clinical outbreaks 
of abortions and respiratory disease (Keffaber 1989), no one in the veterinary scientific 
community was aware that many years after that, many aspects of this disease would remain 
mysterious and unresolved. Since the original emergence of PRRS, it has become one of the 
most economically devastating diseases of pigs. Losses are currently estimated to be $664 
million per year, in the United States (U.S.) alone (Holtkamp 2013). Initial research work related 
to PRRS was focused on determining the etiology of the disease characterized by reproductive 
failure, interstitial pneumonia, and increased mortality in nursing pigs (Hill 1990). In 1991, the 
etiology of European PRRS was discovered to be a previously unknown RNA virus and 
classified into genus Arterivirus of family Arteriviridae (Terpstra 1991; Wensvoort 1991). 
Shortly thereafter, a similar virus was isolated from outbreaks in the U.S. (Collins 1992) and 
Canada (Dea 1992). However, retrospective studies demonstrated that the virus had been 
circulating in North America prior to the initial outbreaks. The earliest evidence of porcine 
reproductive and respiratory syndrome virus (PRRSV) infection in North America used archived 
pig serum from 1979 in Ontario, Canada (Brar 2011). 
PRRS is currently an endemic disease (OIE 2015) and represents a substantial economic 
burden for pork producers in most swine producing regions of the world. Although the accurate 
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reports on the prevalence of disease in the North America are not available, most concerning is 
the high seroprevalence (49.8%) of unvaccinated herds (APHIS 2009). In Canada, two studies 
confirmed higher PRRSV antibody prevalence in market pigs in Quebec (89.9%) than in serum 
samples from Manitoba (54.3%) (Magar and Larochelle 2004). PRRSV seroprevalence in 
Quebec breeding herds was estimated to be 74%  (Lambert 2012). 
Direct financial losses of the clinical effect of disease are due to increased mortality, 
reduced average daily gain, increased treatment cost per pig, reduced feed efficiency, and a 
decrease in reproductive health (Dee 2003). Epidemiological features of PRRSV, characterized 
by many routes of transmission between and within herds, its persistence in herds and rate of 
mutation make current PRRS control efforts challenging, suggesting that PRRS-associated 
economic losses will continue in the future (Holtkamp 2013). Future research work that will 
improve our understanding of epidemiologic characteristics of the PRRSV and pathogenesis of 
the disease is required to help develop new control measures such as vaccines and diagnostic 
tests. 
1.2.2 Reproductive PRRS 
Initial work examining the reproductive form of PRRS described the pathological lesions 
affecting the various fetal organs and the pregnant uterus but did not reveal specific lesions or 
mechanisms that could explain fetal death (Christianson 1993; Lager and Mengeling 1995; 
Rossow 1996b). Furthermore, determining pathogenetic mechanisms of the PRRSV-induced 
disease has proved to be much more challenging than determining the etiology. Although the 
majority of research work has been focused on the respiratory form of the disease in neonatal, 
nursing and growing pigs (Rossow 1995), the breakthrough discovery from these early studies 
was cell-specific tropism of PRRSV to a limited group of blood monocytes and porcine alveolar 
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macrophages (Plagemann and Moennig 1992; Mardassi 1994). Recent studies identifying 
specific receptors on susceptible cells for PRRSV infection (Calvert 2007; Van Gorp 2008; 
Zhang and Yoo 2015) and mechanism of cell death (Sur 1998; Karniychuk 2011; Gómez-Laguna 
2013) have resulted in a renewed interest in the pathogenesis of fetal death in the reproductive 
form of PRRS. 
1.2.3 PRRS transmission  
Horizontal transmission is accomplished through contact between infected and naïve 
animals (Wills 1997a). During the infection PRRSV has been detected in blood, semen, saliva, 
feces, milk and colostrum (Wills 1997a; Christopher-Hennings 1998; Wagstrom 2001; Batista 
2002; Rowland 2003). For example, PRRSV-infected boars shed virus in the semen for an 
extended period after inoculation (92 days) (Christopher-Hennings 1998). When contaminated 
semen enters the uterus, infection apparently begins from the endometrial tissues and regional 
lymph nodes resulting in the haematogenous or lymphoid dissemination of PRRSV (Christopher-
Hennings 1998).  
Vertical transmission of PRRSV has been confirmed, particularly during mid to late 
gestation (Christianson 1993). The exact route of PRRSV transmission from dam to the fetus is 
still not completely understood. One hypothesis is that PRRSV after its primary replication in the 
tonsils and respiratory tract causes viremia through the infection of susceptible blood monocytes. 
Movement of monocytes through the endometrial vessel walls and differentiation into tissue 
macrophages leads to the final migration of the virus to the fetal placenta and fetus (Karniychuk 
and Nauwynck 2013). Part of this hypothesis has been confirmed by identifying  PRRSV-
positive cells between endothelial cells of endometrial blood vessels (Karniychuk 2011). 
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However, following routes of PRRSV transmission from the endometrial tissue across the 
maternal-fetal interface into the fetal placenta during early infection has not been done.  
Indirect transmission can involve inanimate objects (equipment, boots, coveralls) as 
potential sources of PRRSV to naïve pigs (Dee 2002). Needles were also confirmed to be a 
significant source of indirect PRRSV transmission between pigs (Otake 2002b). Also, under 
experimental conditions, PRRSV can be mechanically transmitted on fomites particularly in the 
cold and to a lesser degree warm weather (Dee 2002). Transmission via arthropods such as house 
flies and mosquitos is also confirmed (Otake 2002a; Otake 2003). Finally, aerosol transmission 
is considered as a potentially significant route of PRRSV spread between farms (Dee 2005a). 
Several studies confirmed that aerosol contaminated with PRRSV can infect naïve pigs over 
distances of 0.5 to 150 meters (Kristensen 2004; Dee 2005a; Dee 2005b).  
1.2.4 PRRS immune response  
Innate immunity is the first line of defense against viral infection. Unlike other viruses, 
PRRSV has poor ability to induce secretion of INF-α, which is critical cytokine for the efficient 
antiviral innate immune response in pigs (Lee 2004; Miller 2004). Although IFN-α is induced by 
PRRSV infection (Ladinig 2014c), the overall secretion of INF-α and INF-β cytokines are 
suppressed in vivo (Albina 1998). On the other hand, the early PRRSV infection is dominated by 
up-regulation of INF-γ (Loving 2008) that is positively associated with PRRSV load (Ladinig 
2014c). 
After the weak innate immune response of infected macrophages, the humoral immune 
response first appears 5-7 days post-infection (DPI) with PRRSV-specific IgM in the serum 
(Díaz 2005). However, at this time the most abundant antibodies are non-neutralizing (Ostrowski 
2002). Neutralizing antibodies are detected in the serum as early as three weeks post infection, 
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but at the low levels (Loemba 1996). GP5 protein of PRRSV is confirmed to incite majority of 
neutralizing antibodies (Mateu and Diaz 2008). M and N proteins are also responsible for 
induction of smaller portion of neutralizing antibodies (Mulupuri 2008). In some animals, during 
the PRRSV infection, viremia can occur in the presence of neutralizing antibodies which 
suggests that humoral immune response is not a critical factor for viral elimination (Yoon 1996).  
The cellular-mediated immune response is primarily composed of T-cells specific for 
structural proteins of the virus, but it is transient and is not correlated with the PRRSV load in 
the tissue and the resolution of the infection (Xiao 2004; Rascón-Castelo 2015). Early PRRSV 
infection (2 DPI) was confirmed to cause marked leukopenia affecting primarily lymphocytes 
(Ladinig 2014b). However, after 6 DPI the numbers of inflammatory cells starts to recover and 
marked lymphocyte proliferation develops especially after four weeks post-infection (López 
Fuertes 1999). 
Poor innate immunity due to alteration of cytokine secretion in cooperation with weak 
and delayed acquired immunity both humoral and cellular-mediated leads to prolonged acute and 
subsequent development of persistent infection (Wills 2003; Mateu and Diaz 2008).  
1.2.5 Strategies for control and eradication of PRRS 
Identification of risk factors for PRRSV infection at the herd level is essential and the 
first step in determining efficient control, eradication measures and cost effective surveillance 
strategies (Velasova 2012). It has been found that increased herd size, distance to the 
neighboring pig herds and exposure to infected semen are significantly associated with increased 
risk of PRRSV infection (Mortensen 2002). Additionally, total confinement housing, pig density, 
a greater number of purchases of gilts and boars, and poor management and biosecurity practices 
are found to be significant risk factors (Weigel 2000). Recently to the list of risk factors is added 
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the application of the live virus vaccine at the farm (Velasova 2012). Present identification of 
carrier animals is not fast, accurate or economical, particularly because viremia or 
seroconversion are not reliable criteria for identification of persistently infected animals (Wills 
1997b). Hence, the presence of carrier animals in a swine population represents an additional risk 
factor.  
The ultimate goal of every control strategy is the production of PRRSV-negative weaned 
piglets (Holtkamp 2011). In other words, it is required to prevent both vertical and horizontal 
transmission of the PRRSV in the breeding herd and to establish so-called "stable" herd (Corzo 
2010). A subcommittee was formed by the American Association of Swine Veterinarians and the 
United States Department of Agriculture in order to classify herds by PRRSV infection/shedding 
and exposure status of the breeding herd (Holtkamp 2011). The classifications are listed here: 
 
Positive unstable (I) Breeding herds actively shed virus and are exposed to the virus 
(undergoing acute PRRS outbreak or repeated chronic) 
Positive stable (II) Absence of clinical signs of PRRS in the breeding herd and 
absence of viremia in weaning-age pigs for 90 days 
II-B are undergoing elimination and II-A are not 
Provisional negative (III) Negative shedding, but positive exposure status 
Negative (IV) both negative shedding and exposure status 
 
Numerous control measures can be used to stabilize breeding herd. In this review, only a 
few reported to be the most effective are described below.  
Strict implementation of biosecurity measures for prevention of reinfection of the herds is 
still essential control measure (Corzo 2010). Systematic cleaning and disinfection between 
groups of pigs combined with separation of production units into individual rooms are effective 
control measures to reduce the horizontal transmission between infected and newly moved 
animals (Dee, 2003). This control strategy is known as “all-in/all-out” (AIAO) (Pitkin 2015).  
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 “Management Changes to Reduce Exposure to Bacteria to Eliminate Losses” 
(McREBEL) is simple and low-cost control strategy consisting of a systematic series of measure 
with a goal to decrease the spread of PRRSV and secondary bacteria among piglets (McCaw 
1995). It can repeatedly be applied to unstable herds and includes the reduction of cross-fostering 
and elimination of weak, thin or “poor doing” piglets (Dee 2003). 
Obtaining efficient protective immunity against PRRSV is another possible strategy for 
control of the disease. Vaccinated pigs can develop sufficient active immunity to be protected 
against reproductive effects of PRRSV infection after the exposure to homologous PRRSV 
(Yoon 1996). First commercially available vaccines came out in the early nineteen-nineties. 
They were modified-live vaccine (MLV) designed for type 2 PRRSV strains (Renukaradhya 
2012). PRRSV-MLV vaccines have been successfully used for many years in North America. 
However, disadvantages of these vaccines are concerns for potential MLV virus replication in a 
herd, reversion of the MLV strain to pathogenicity and lack of cross-protection for many field 
strains (Charerntantanakul 2012). Antigenic and genetic variation of PRRSV is the most 
responsible factor in repeated outbreaks of this disease and the main difficulty for the 
development of an effective vaccine against PRRSV infection (Renukaradhya 2015). On the 
other hand, inactivated vaccines are safe, but there are concerns about their efficacy (Geldhof 
2012). 
A promising strategy to control PRRS is the development of genetically resistant breeds 
of pigs (Lunney and Chen 2010). It was observed that some breeds of pigs, when infected with 
PRRSV, develop more severe clinical signs than others (Halbur 1998). Numerous studies in this 
research area have found that multiple immunological factors play a major role in different breed 
response to PRRSV infection. For example, different levels of expression of CD169 receptors on 
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the PRRSV susceptible population of macrophages and cytokines such as TNF-α, IL8  (Ait-Ali 
2007) or in the reproductive form of the disease, INF- γ (Lowe 2005). Furthermore, it was found 
in the nursery pigs that selection for a specific trait can also be an important factor for the 
outcome of PRRSV infection (Petry 2007). Hence, animals that were growing faster have been 
experiencing a more acute form of PRRSV infection (Doeschl-Wilson 2009).  
A recent study of the role the host genetics during the PRRSV infection has confirmed 
that nursing pigs can be categorized based on the PRRSV viral load into resistant and tolerant 
phenotypic groups (Boddicker 2012). The tolerant phenotype in this study gained weight (close 
to non-infected control pigs) even though these pigs had acute outbreak levels of PRRSV load 
(Boddicker 2012). This finding has led to the identification of a region on chromosome 4 (SSC4) 
which was correlated with this resistance (Boddicker 2014). Recently, the putative causal 
mutation was confirmed in the region of Guanylate Binding Protein 5 (GBP5) at the major 
quantitative trait locus (QTL) of SSC4 (Koltes 2015). The GBP5 protein is an important 
mediator of inflammatory immune response in mammals and plays an important role in 
inflammasome assembly (Shenoy 2012). GBP5 host genetic variation is responsible for the host 
response to PRRSV infection (Koltes 2015). These results may serve as new opportunities for 
development of breeding programs for production of pigs with increased resistance to PRRSV 
infection and high growth rate at the same time (Rowland 2012).  
Eradication of PRRSV can be accomplished through many methods such as whole herd 
depopulation and repopulation, test and removal, and herd closure and rollover (Corzo 2010). 
Whole herd depopulation and repopulation is characterized by the elimination of all animals 
from the farm, disinfection of the facilities and introduction into the farm PRRSV-negative pigs 
(Rowland and Morrison 2012). This method is very effective, but very costly and rarely is used 
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in the big production systems (Rowland and Morrison 2012). Test and removal elimination 
method include determining exposure status of the breeding herd and subsequent removing of all 
seropositive animals (Dee 2001; Dee 2003). The weakness of this approach is the cost of 
diagnostics and early removal of PRRSV exposed animals from production system (Dee 1996). 
Herd Closure and Rollover is the most widely used method for eliminating PRRS from sow 
herds (FitzSimmons and Daniels 2003). This method is characterized by the gradual extinction of 
PRRSV in herds that are closed for 200 days. Then seropositive sows are removed and replaced 
with negative pigs (FitzSimmons and Daniels 2003). It is reported that this elimination method is 
the least expensive (Fraile 2012). However, the biggest risk factor and the weakness of all 
elimination programs is still potential reinfection of the herd with new and unrelated PRRS strain 
to developed immunity.  
Finally, PRRSV regional elimination has been shown to be a promising and potentially 
effective way to control the disease at a regional or national level (Corzo 2010). Successful 
examples including Chile and Sweden on the national level, and Stevens County, Minnesota on 
regional level suggest that control and elimination programs can be only accomplished through 
close communication and coordinated cooperation between government, industry and swine 
veterinarians (Corzo 2010). 
1.3 Mechanisms of reproductive PRRS 
1.3.1 PRRSV infection  
The process of PRRSV infection is still not completely understood. However, the ability 
of PRRSV to replicate in a permissive subpopulation of local tissue macrophages before its 
subsequent spreads to lymphoid organs, lungs, and other tissues, is the first and critical step in 
this process (Thanawongnuwech 1997b). The primary cell population for viral replication is a 
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well-differentiated subset of monocyte-derived cells, such as PAM and PIM in the lung 
(Thanawongnuwech 1997a; Thanawongnuwech 2000b) and macrophages in lymphoid tissue 
(Rossow 1998). It is also described in the literature that PRRSV can also replicate in microglia 
cells (Rossow 1996a). Also, acute PRRSV infection can over time become a persistent infection 
since the virus can continue to replicate in susceptible cells even when significant humoral and 
cellular immunity has been developed (Horter 2002). An example of this was PRRSV-infected 
35-day-old pigs which remained persistently infected for several months (Wills 1997b). 
Additionally, since PRRSV replicates in the macrophages, a significant loss in macrophage 
numbers during infection can predispose the host to potential infections with secondary 
pathogens (Costers 2008). Pigs infected with PRRSV often experience more severe secondary 
infections with bacterial or viral pathogens such as Mycoplasma hyopneumoniae, Salmonella 
choleraesuis, Haemophilus parasuis, Streptococcus suis, Pasteurella multocida, and influenza A 
virus (Thanawongnuwech 2000a; Brockmeier 2002; Zimmerman 2012). 
Several studies have confirmed that PRRSV can cause transplacental infection of a fetus 
after experimental and natural infection of the sow (Lager and Mengeling 1995; Mengeling 
1996; Nielsen 2002; Karniychuk and Nauwynck 2013). The absence of microscopic lesions in 
the internal organs of stillborn piglets suggests that fetal death may not be a consequence of 
PRRSV replication in the internal organs of fetuses (Rossow 1996b; Karniychuk and Nauwynck 
2013). More recent research findings suggest that the maternal-fetal interface plays a significant 
role in the pathogenesis of transplacental PRRSV infection (Karniychuk 2011). 
1.3.2 Properties of virus 
There are two genetically distinct types of PRRSV: Type 1 (European genotype) and 
Type 2 (North American genotype). Both types are found in North America, Europe, and Asia 
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(Plagemann 2003; Dietze 2011). Differences between Type 1 and Type 2 are estimated to be 
40% of the whole genome (Hanada 2005). Presently, Type 2 PRRSV consists of 9 distinct 
genetic lineages, and Type 1 has at least four subtypes described as pan-European subtype 1 
“Lelystad virus-like”, Eastern European subtypes 2 and 3, and subtype 4 from Belarus and Latvia 
(Salguero 2015). A recently discovered highly pathogenic East European subtype 3 PRRSV 
isolate, named “Lena,” was confirmed to be antigenically and genetically different from other 
Type 1 strains (Karniychuk 2010). In addition to their genetic differences, Type 1 and Type 2 
PRRSV strains also demonstrate differences in pathogenicity in vitro and in vivo (Choi 2015). 
Type 2 PRRSV grow easily on MARC-145 cells while type 1 PRRSV have to be adapted for in 
vitro growth on cells other than myeloid pig cells (PAM) (Salguero 2015). In vivo evidence 
suggest that respiratory disease caused by type 1 PRRSV is less severe than by type 2 (Choi 
2015). Furthermore, outbreaks of more severe disease were more often linked to Type 2 than to 
Type 1 PRRSV infection (Tian 2007). Examples are the emergence of Highly Pathogenic 
Porcine Reproductive and Respiratory Syndrome (HP-PRRSV) related to a novel Type 2 PRRSV 
strain, observed in China in 2005 (Tian 2007).  
The PRRSV genome is long 15 kb and possesses eight open reading frames (ORFs) (Dea 
2000). In the past, restriction fragment length polymorphism (RFLP) of ORF5 was used for 
PRRSV typing confirming numerous RFLP cut patterns of PRRSV. Although RFLP 
demonstrated to be useful in differentiating vaccine from field strains, sequencing revealed that 
genetically diverse viruses shared the same cut patterns and vice versa (Brar 2011).  
ORF 1a and ORF 1b compromise most of the viral genome, and encode RNA replicase 
required for virus replication and are translated into 12 smaller nonstructural proteins (nsp) 
(Snijder and Spaan 2007). Beside the role of nsp in PRRSV replication, they also have a role in 
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host immune response to PRRSV (Oleksiewicz 2001). Interestingly, both HP-PRRSV and Lena 
strain have a similar deletion in the nsp2 part of ORF1, a mutation which may be responsible for 
the observed higher pathogenicity of these strains (Weesendorp 2013). Structural proteins are 
GP5, M, and N protein (Dea 2000). GP5 is the protein of the virus envelope which during 
infection is responsible for recognition of specific cell receptors (Vanderheijden 2003). 
Transmembrane M is the genetically conserved protein and has a function in virus assembly and 
budding (Mardassi 1996). This protein forms disulfide-linked heterodimers that are essential for 
interaction with cellular receptors and virus infectivity (Mardassi 1996). N protein interacts with 
viral RNA in the assembly of infectious particles, and it is the most abundant protein (40%) 
protein in the virion (Yoo 2003).  
A unique property of PRRSV along with other Arteriviruses is a relatively high mutation 
rate, which is responsible for continuous antigenic and genetic variation of field strains 
(Murtaugh 2010; Kappes and Faaberg 2015). Mutation and recombination are responsible for 
genetic variations, but the viral diversity is also a result of factors such as transmission, 
management and vaccination practices and pig genetic variations (Shi 2010). These features of 
PRRSV make the design of effective vaccines and diagnostic methods challenging 
(Renukaradhya 2015).  
1.3.3 Cell susceptibility  
In addition to the susceptible subpopulation of local tissue macrophages such as 
pulmonary alveolar macrophages (PAM) and intravascular macrophages (PIM) in the lung 
(Thanawongnuwech 1997a; Thanawongnuwech 2000b) and macrophages in lymphoid tissue 
(Rossow 1998), there are rare reports of PRRSV ability to infect other cell types. Various 
immortalized and primary cell lines have been able to support PRRSV growth: primary pig 
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macrophages (PAM and PIM), porcine endometrial endothelial cells (PEE) expressing 
sialoadhesin (CD169) and CD151, but not CD163 (Feng 2013), MARC-145 (green monkey 
kidney) cells, CL 2621, and PK-15 expressing CD163 and sialoadhesin (Delrue 2010; Provost 
2012). PRRSV infection of nasal, bronchiolar, alveolar epithelium and endothelial cells has been 
reported, although the mechanism of the PRRSV infection of these cell types remains 
unexplained (Rossow 1996a; Thanawongnuwech 1997a; Rossow 1998). 
1.3.4 Receptors 
The PRRSV enters susceptible macrophages through receptor-mediated endocytosis (Van 
Gorp 2008). Several cell receptors are mentioned in the literature as necessary for PRRSV 
attachment and entry into the permissive cell types (Zhang and Yoo 2015).  
Attachment of Type 1 PRRSV to target cells is believed to be accomplished by primary 
interaction with the sialoadhesin (CD169) receptor (Vanderheijden 2003). CD169 receptors can 
be found in the subgroup of macrophages in the splenic, hepatic, lymphatic, pulmonary 
hematopoietic tissue (Hartnell 2001). CD169 is responsible for interactions between cells 
through the binding of sialic acid ligands on monocytes, NK cells, B cells, and some cytotoxic T-
cells (Martinez-Pomares and Gordon 2012). Also, it participates in the adaptive immunity, 
processing of the antigen, presentation to T cells, activation of B cells and CD8+ T cells (O'Neill 
2013). Recent studies with porcine CD169 suggest it has a role as an endocytic receptor in 
“targeted delivery” of antigens to macrophages (Delputte 2011).  
A molecule found to facilitate the attachment of PRRSV to susceptible cells is heparan 
sulfate. It was confirmed that heparan sulfate in vitro can bind to M and N proteins of the 
PRRSV (Delputte 2002). One study  hypothesized that heparan sulfate is required for initial 
weak attachment of the virus to the susceptible cells leads to stronger interaction with the CD169 
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receptor (Zhang and Yoo 2015). Unfortunately, no subsequent studies have confirmed an 
essential role for heparan sulfate in PRRSV infection (Delputte 2005).  
Another important receptor ligand for PRRSV infection of susceptible macrophages is 
the CD163 entry mediator (Van Gorp 2008). CD163 is a membrane protein present primarily on 
some types of macrophages and monocytes (Møller 2012). CD163 is so-called macrophage 
scavenger receptor with numerous roles in processes such as uptake of haptoglobin-hemoglobin 
complexes, erythroblast adhesion, innate immunity of bacteria, and apoptosis (Etzerodt and 
Moestrup 2013).  
In pigs, CD163 has been reported to be entry mediator into macrophages for PRRSV and 
African swine fever virus (Møller 2012). In vitro studies have shown that both receptors, CD169, 
and CD163, are required for PRRSV infection (Van Gorp 2008). Also, it has been reported that 
both CD169 and CD163 positive macrophages demonstrated significant quantitative changes at 
the maternal-fetal interface, pig embryos, and fetuses during gestational infection with Type 1 
PRRSV (Karniychuk and Nauwynck 2009). One model of infection proposes that type 2 PRRSV 
is using CD169 receptor to attach to susceptible cells and CD163 to enter into the cytoplasm of 
susceptible cells through the process of endocytosis (Whitworth 2016). 
CD151 is a recently described cell-surface protein  which was found in the population of 
newly discovered PRRSV susceptible St-Jude porcine lung (SJPL) cells (Provost 2012). In vitro 
infection of SJPL cells confirmed that CD151 downregulation in the cells decreases the amount 
of PRRSV replication (Wu 2014). Since this cell line does not have CD163 and CD169 
receptors, the role of CD151 in vivo is unknown. CD151 was also found on porcine endometrial 
endothelial (PEE) cells derived from the primary endothelial cells originating from the uterine 
microcirculation which are susceptible to PRRSV infection in vitro (Feng 2013). PEE cells are 
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CD169 and CD151 positive, but CD163 negative, suggesting that these two receptors may act as 
possible alternatives for attachment of type 1 PRRSV attachment on some cells (Provost 2012).  
DC-SIGN (dendritic cell-specific intercellular adhesion molecule-3-grabbing non-
integrin) or CD209 is an adhesion receptor present on macrophages and dendritic cells detected 
on PRRSV susceptible BHK-21 cell line can enhance the viral transmission from the engineered 
BHK donor cells to target MARC-145 cells (Huang 2009). 
1.3.5 Cellular damage 
It was hypothesized that PRRSV induces cellular damage and subsequent pathological 
lesions by a variety of mechanisms. The most relevant mechanisms of apoptosis and 
inflammation of the vasculature are discussed in this section. 
1.3.5.1 Apoptosis 
Apoptosis is a well-described mechanism of cell death in the pathogenesis of viral 
infections (Roulston 1999). Viruses induce apoptosis of susceptible cells to promote viral spread 
in the tissue and prevent efficient immune response (Roulston 1999). 
Previous studies confirm that PRRSV can induce apoptosis during infection (Sur 1997; 
Kim 2002; Miller and Fox 2004). Under in vitro experimental conditions apoptosis of PRRSV-
infected cells has been well described (Kim 2002). More specifically, in the early PRRSV 
infection of macrophages the infected cells are protected from the apoptosis, but as infection 
continues, infected cells undergo apoptosis suggesting that PRRSV modulates mechanisms of 
programmed cells death (Costers 2008). An in vitro experiment on  MARC-145 cells confirmed 
that PRRSV regulates apoptosis by activation of extrinsic pathway of apoptosis (Lee and 
Kleiboeker 2007). In vivo studies also revealed that apoptotic cells can be found in the variety of 
tissues from PRRSV-infected pigs (Sur 1998; Labarque 2003; Chang 2005; Costers 2008). 
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Additionally, the number of apoptotic cells detected in the lymphatic tissue of experimentally 
PRRSV infected pigs is higher than a number of infected cells (Gómez-Laguna 2013). The 
majority of apoptotic cells during the PRRSV infection are macrophages and lymphocytes in the 
lungs and lymphatic organs (Labarque 2003). Besides apoptosis, PRRSV antigen is often 
associated with necrosis as well (Miller and Fox 2004; Lee and Kleiboeker 2007).  
Increased apoptosis affecting macrophages and lymphocytes is also detected in the fetal 
placental tissue and endometrium at the maternal-fetal interface of Type 1 PRRSV-infected 
pregnant sows (Karniychuk 2011). Since many of the apoptotic cells were also negative for 
PRRSV (Miller, 2004) or not previously described as permissive such as lymphocytes (Gómez-
Laguna 2013) , it is hypothesized that PRRSV can induce apoptosis not only directly by infecting 
susceptible cells, but also by some still unknown indirect mechanism (Flores-Mendoza 2008).  
Indirect apoptosis in bystander cells appears to be an important mechanism in PRRSV-
induced cells death, but how the virus induces it, still needs to be explained. One of the potential 
mechanism is up-regulation of secretion of the pro-apoptotic inflammatory cytokines (Lee and 
Kleiboeker 2007). Nevertheless, numerous studies have confirmed that apoptotic cells are 
detected in PRRSV-infected cultured cells, tissues and animals and that these apoptotic cells 
contribute to the pathology (Prieto 1997).  
In summary, future studies of PRRSV-induced apoptosis in the reproductive form of 
PRRS, either through examination of pro-apoptotic gene expression during PRRSV infection or 
testing apoptotic markers are needed. More specifically, it is necessary to examine the 
association between PRRSV load and the apoptosis at the maternal-fetal interface and fetus 
during the transplacental infection of the fetus, because this information could potentially 
elucidate the role of apoptosis in fetal death.  
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1.3.5.2 Vasculitis  
Vasculitis or inflammation of vasculature can demonstrate as a primary disease with no 
detectable cause (idiopathic) and/or secondary as a result of inflammation, malignancy or 
autoimmune disease (Luzina and Handwerger 2000). Vasculitis can affect vasculature at all 
levels from microvasculature to large caliber blood vessels (Luzina and Handwerger 2000).  
In pigs, widespread vasculitis has been described for infections with PRRSV, African 
swine fever virus, classical swine fever virus, bovine viral diarrhea virus (BVDV), ovine 
herpesvirus type 2, pseudorabies virus, porcine circovirus type 2, Salmonella choleraesuis, 
Streptococcus suis, Escherichia coli, and Erysipelothrix rhusiopathiae (Langohr 2010).  
Pathophysiology of secondary vasculitis is complex and involves several mechanisms 
(Guillevin and Dörner 2007). Only the mechanisms of vasculitis that are relevant to PRRSV 
infection are described herein.  
Many infectious agents can cause direct damage to the endothelial lining of blood vessels 
and subsequent vasculitis (Belizna 2009). This type of primary vasculitis is accomplished if 
pathogens have a tropism to infect endothelial cells such as equine arteritis, infectious canine 
hepatitis, canine distemper, African swine fever, and classical swine fever (Maxie and Robinson 
2007). Also, damage to endothelium can also be accomplished through the production of various 
toxic products secreted by pathogens such as endotoxins of gram-negative bacteria (e.g., 
Mannheimia haemolytica), or exotoxins of bacteria (e.g., Actinobacillus pleuropneumoniae, 
Histophilus somni) (Maxie and Robinson 2007). This first mechanism is suspected to be 
responsible for PRRSV-induced vasculitis since PRRSV antigen has occasionally been detected 
in the endothelial cells (Halbur 1995). Although, it remains unclear how the virus enters 
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endothelial cells, the recently discovered CD151 receptors on PEE cells (Feng 2013) suggest a 
potential mechanism of entry.  
Another potential mechanism of primary vasculitis is immune complex (type III 
hypersensitivity) reaction (Belizna 2009). In animals, immune complexes can be detected in the 
inflamed blood vessel walls in many diseases such as systemic lupus erythematosus, Aleutian 
disease of mink, feline infectious peritonitis and porcine dermatitis and nephropathy syndrome 
(PDNS) (Maxie and Robinson 2007). The pathogenesis of this type of vasculitis is characterized 
by precipitation of increased amounts of antigens and specific antibodies within vessel walls 
(basement membrane), which activates the complement, attract neutrophils and incite necrotizing 
vasculitis (Millikan and Flynn 1999). Since it has been confirmed in the past that PRRSV 
infection causes delayed humoral immune response characterized by low titer of neutralizing 
antibodies (Labarque 2000), this mechanism is less likely to be a cause of PRRSV-induced 
vasculitis.  
Other mechanisms of primary vasculitis include cell-mediated (type IV hypersensitivity) 
reaction, abnormal immune regulation due to abnormal expression of adhesion molecules on 
pathogen infected endothelial cells and overproduction of cytokines by direct stimulation from 
the infectious agents (Manders 1998; Weyand and Goronzy 2003; Belizna 2009). All of these are 
even less likely to play a role in PRRSV infection. 
PRRSV-induced vasculitis can vary in its distribution and severity, and affect all sizes of 
blood vessels (Rossow 1995). PRRSV-associated vasculitis was initially described as severe 
necrotizing and leukocytoclastic with thrombosis, affecting chiefly post-capillary venules of the 
skin and kidneys (Thibault 1998). In PRRSV-infected, gnotobiotic pigs between 3 and 21 days 
post-inoculation, lymphohistiocytic inflammation was described in the thoracic aortas, as well as, 
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numerous arterioles and veins (Rossow 1995). The damage to the endothelium of the inflamed 
blood vessels along with fibrinoid vascular necrosis of the tunica media was occasionally 
reported as well (Cooper 1997). 
1.3.6 Fetal and maternal pathology  
Reproductive PRRS is principally characterized by acute viremia and transplacental 
transmission resulting in reproductive failure (Rossow 1998). In sows, mortality reaches 1-4% 
during acute illness (Hopper 1992). Acute PRRSV infection in sows and gilts can range from no 
apparent clinical signs of fever, anorexia, lethargy, and severe respiratory clinical signs 
(Christopher-Hennings 1998).  
Gross pathological lesions of the reproductive form of PRRS in the sows are commonly 
demonstrated by variable degrees of endometrial and myometrial edema, endometritis, and 
myometritis (Caswell and Williams 2007). "Paintbrush" hemorrhages have been observed in the 
placenta and petechial hemorrhages, and necrosis occurs in umbilical vessels, skin, and renal 
cortex (Rossow 1998). Microscopic pathological lesions present in the myometrium and 
particularly endometrium consist of edema and lymphoplasmacytic and lymphohistiocytic 
myometritis and endometritis (Lager and Halbur 1996). Lymphoplasmacytic segmental vasculitis 
and marked microseparations between endometrial epithelium and placental trophoblasts can 
occasionally be observed, as well (Lager and Halbur 1996).  
Lesions in aborted fetuses, dead fetuses, and stillborn piglets are uncommon, but the 
absence of lesions in fetuses does not rule out PRRSV (Schlafer and Miller 2007). Dead fetuses 
are commonly covered with a thick brown mixture composed of meconium and amniotic fluid. 
This finding may non-specifically suggest fetal stress and hypoxia (Lager and Halbur 1996). 
Most of the lesions found in the fetuses are variable, non-specific, often obscured by autolysis 
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and inconsistent for PRRSV infection (Rossow 1998). Grossly, they include perirenal edema, 
edema of the splenic ligament, mesenteric edema, ascites, hydrothorax, and hydroperitoneum  
(Lager and Halbur 1996).  
Microscopic lesions in live piglets may include mild to moderate, multifocal to diffuse, 
histiocytic and proliferative interstitial pneumonia characterized by mononuclear cell septal 
infiltration (Caswell and Williams 2007). Hypertrophy and hyperplasia of type 2 pneumocytes 
are occasionally present (Rossow 1998). Mild segmental necrotizing and lymphohistiocytic 
arteritis has been seen in lungs (Caswell and Williams 2007). Mild lesions in the heart and liver 
are also multifocally present composed of lymphohistiocytic inflammation and rare hemorrhage 
(Lager and Halbur 1996).  
Finally, an important diagnostic lesion that can occur in some cases is a segmental 
hemorrhage of umbilical cord characterized by segmental lymphoplasmacytic and sometimes 
necrosupparative vasculitis (Lager and Halbur 1996). 
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2 Rationale, hypotheses and objectives 
Despite nearly 25 years of research work, the underlying mechanisms of fetal death in the 
reproductive form of PRRS are still undetermined. The main body of literature regarding the 
critical factors of PRRSV infection and PRRSV-induced mechanisms of cellular death represent 
experiments done either in vitro or for the postnatal respiratory form of the disease. Similarly, 
studies of the reproductive form of PRRS are sparse, often investigating single pathogenetic 
factors and having contradictory conclusions between investigations. Recent studies begin to 
challenge the previous understanding of fetal death as a result of PRRSV replication in the fetal 
tissues, proposing conversely that pathological processes at the maternal-fetal interface are 
responsible for fetal death (Rowland 2010; Karniychuk 2011).  
Additionally, scientific knowledge regarding essential factors of transplacental infection 
of the fetus are still in the unproven hypothesis stage (Karniychuk and Nauwynck 2013). 
Therefore, there is a need for large-scale studies on the reproductive form of PRRS that will 
provide more insight into the process of infection within the uterus and fetus. Critical 
information is needed to understand the relationships between specific pathological lesions, their 
severity and PRRSV infection, along with the role of PRRSV replication, PRRSV susceptible 
cells and cell death on both the maternal and fetal sides of the maternal-fetal interface. Once we 
understand all critical factors of fetal disease and death, we can develop new treatments and 
vaccines that will be effective in preventing them.  
The following hypotheses were developed to examine the mechanisms of PRRSV fetal infection:  
Hypothesis 1: There is a significant association between PRRSV load in the MFI and the fetus 
of the PRRSV-infected gilts in the third trimester of gestation, and PRRSV-associated 
microscopic lesions in the fetal tissues, uterus and fetal placenta. 
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Hypothesis 2: There is a significant association between PRRSV load in the MFI and the fetus 
and the numbers of PRRSV, CD163 and CD169 positive PRRSV susceptible cells, areolae and 
apoptotic cells at the MFI. 
Hypothesis 3: There is a significant association between degree of cellular death (apoptosis) at 
the MFI and PRRSV-associated microscopic lesions in the fetal tissues, uterus and fetal placenta 
during type 2 PRRSV infection of late gestation pregnant gilts.  
Hypothesis 3: There is a significant relationship between fetal preservation status and PRRSV-
associated microscopic lesions in the fetal tissues, uterus, fetal placenta, and the degree of 
cellular death at MFI. 
The following specific objectives for this study were developed to test these hypotheses: 
Objective 1. To qualitatively assess the PRRSV-associated microscopic lesions in the fetal 
tissues, uterus and placenta.  
Objective 2. To develop a grading scheme and assess the severity of microscopic lesions 
associated with PRRSV infection at the MFI.  
Objective 3. To determine relationships between the severity and distribution of microscopic 
lesions, PRRSV RNA concentration in the MFI and the fetus, and fetal preservation status.  
Objective 4. To identify, localize and quantify PRRSV antigen, CD163 and CD169, TUNEL 
positive cells, and cathepsin-L positive areolae in the MFI.  
Objective 5. To evaluate the relationship between numbers of CD163, CD169 positive cells, 
TUNEL positive cells in the endometrium and fetal placenta, and cathepsin positive areolae at 
the MFI and PRRSV load in the MFI and fetal thymus.  
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Objective 6. To evaluate the relationship between histopathological grades of inflammation in 
the endometrium and blood vessels, and the numbers of TUNEL positive cells at the MFI in type 
2 PRRSV-infected pregnant gilts.  
Objective 7. To evaluate the relationship between numbers of TUNEL positive cells at the MFI 
and odds of the fetus being meconium stained or viable (preservation status of the fetus). 
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3 Pathologic evaluation of type 2 porcine reproductive and respiratory syndrome virus 
infection at the maternal-fetal interface of late gestation pregnant gilts 
 
This chapter represents the initial microscopic pathology assessments during the type 2 PRRSV 
infection of pregnant gilts in the late gestation. The initial assessments were for the absence or 
presence of a lesion in the uterine and fetal samples. Furthermore, histological scoring schemes 
were developed for the purpose of evaluation the relationships between the severity of 
pathological lesions and PRRS virus load in the maternal-fetal interface.  
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3.1 Abstract 
The pathogenesis of fetal death caused by porcine reproductive and respiratory syndrome 
virus (PRRSV) remains unclear. The objective of this study was to improve our understanding of 
the pathogenesis by assessing potential relationships between specific histopathological lesions 
and PRRSV RNA concentration in the fetuses and the maternal-fetal interface. Pregnant gilts 
were inoculated with PRRSV (n=114) or sham inoculated (n=19) at 85±1 days of gestation. 
Dams and their litters were humanely euthanized and necropsied 21 days later. PRRSV RNA 
concentration was measured by qRT-PCR in the maternal-fetal interface and fetal thymus 
(n=1391). The presence of fetal lesions was positively related to PRRSV RNA concentration in 
the maternal-fetal interface and fetal thymus (P<0.05 for both), but not to the distribution or 
severity of vasculitis, or the severity of endometrial inflammation. The presence of fetal and 
umbilical lesions was associated with greater odds of meconium staining (P<0.05 for both). The 
distribution and severity of vasculitis in endometrium were not significantly related to PRRSV 
RNA concentration in the maternal-fetal interface or fetal thymus. Endometrial inflammation 
severity was positively related to distribution and severity of vasculitis in the endometrium 
(P<0.001 for both). Conclusions from this study suggest that type 2 PRRSV infection in 
pregnant gilts induces significant histopathological lesions at maternal-fetal interface, but they 
are not associated with the presence of PRRSV in the maternal-fetal interface at 21 days post 
infection. Conversely, fetal pathological lesions are associated with the presence of PRRSV in 
the maternal-fetal interface and fetal thymus, and meconium staining is significantly associated 
with the presence of both fetal and umbilical lesions observed 21 days post infection.   
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3.2  Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most 
important viral pathogens in swine production worldwide, causing one of the most costly 
diseases facing the North American swine industry with production losses estimated to be $664 
million USD every year in the USA (Holtkamp 2013). PRRSV is an enveloped, positive-
stranded RNA virus, belonging to the genus Arterivirus, family Arteriviridae, in the order of 
Nidovirales (Done 1996; Rossow 1998). All arteriviruses feature cytopathic replication in 
macrophages, the capacity to develop and preserve an asymptomatic infection, and cause severe 
and fatal disease (Plagemann 2003). Clinical presentation of the syndrome caused by PRRSV 
varies considerably between herds, ranging from asymptomatic to devastating disease 
(Zimmerman 2012). The severity of PRRS clinical signs is influenced by virus strain involved, 
host immune status, genetic susceptibility (Boddicker 2014), concurrent infections and other 
management factors (Done 1996). Clinical disease in pregnant females is characterized by acute 
viremia and transplacental transmission in mainly third trimester resulting in reproductive failure 
(Rossow 1998; Karniychuk and Nauwynck 2013).  
In the reproductive form of PRRS in late gestation gilts or sows, gross and microscopic 
lesions are frequently located in the uterus, both in cases of natural and experimental PRRSV 
infection (Christianson 1993; Lager and Halbur 1996). The myometrium and particularly 
endometrium are characterized by marked edema with lymphoplasmacytic and histiocytic 
endometritis with perivascular cuffing. Occasionally, segmental lymphoplasmacytic vasculitis 
and marked microseparations between endometrial epithelium and placental trophoblasts can be 
observed (Rossow 1998). Infected sows and gilts farrow between 100-118 days of gestation with 
litters composed of variably sized normal, weak, and dead piglets that can be fresh stillborn 
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(intrapartum death), autolytic, partially mummified or completely mummified (Christianson 
1993; Lager and Mengeling 1995; Rowland 2003). Some dead and viable fetuses are covered 
with a brown mixture composed of meconium and amniotic fluid. Gross and microscopical 
lesions are mostly present in the umbilical cord and less often in the internal organs of fetuses 
(Rossow 1998). Meconium staining of the fetuses indicates the occurrence of fetal stress during 
gestation, however,the specific pathogenic mechanism is unclear. Hypoxia was hypothesized to 
play an important role, but whether it is caused by disruption of the blood flow through the 
umbilical cord or due to lesions at the maternal-fetal interface still needs to be revealed (Lager 
and Halbur 1996).  
Despite nearly 25 years of PRRS research, the primary mechanism of PRRSV-induced 
reproductive failure is poorly understood. The absence of significant microscopic lesions in the 
internal organs of stillborn piglets suggests that the fetal death might not be a sequela of PRRSV 
replication in the fetal tissues (Karniychuk 2011). Recent studies propose that type-1 PRRSV 
replication within the fetal placental mesenchyme causing severe histopathological lesions at 
maternal-fetal interface in the third trimester of gestation is responsible for PRRSV-related 
reproductive disease (Karniychuk and Nauwynck 2013). One recent study with type 2 PRRSV 
infection found a lack of correlation between the presence of gross abnormalities in the fetus and 
productive fetal infection suggesting the source of reproductive pathology is potentially infection 
of tissues on the maternal side, damage to maternal tissues, or production of maternal factors that 
affect the fetus (Rowland 2010). However, no published studies to date have investigated the 
relationship between the presence of the PRRSV in the uterus and the fetus and the severity and 
distribution of lesions at maternal-fetal interface, or evaluated potential involvement of maternal-
fetal interface lesions in fetal death. The pathologic evaluation of a large dataset of the maternal-
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fetal interface may cast some new information on the pathogenesis of transplacental PRRSV 
infection.  
The objectives of this study were to: 1) qualitatively assess the PRRSV-associated 
microscopic lesions in the fetal tissues, uterus and placenta; 2) develop a grading scheme and 
assess the severity of microscopic lesions associated with PRRSV infection at maternal-fetal 
interface and fetuses; and 3) determine relationships between the severity and distribution of 
microscopic lesions, PRRSV RNA concentration in the maternal-fetal interface and the fetus, 
and fetal preservation status. 
3.3  Material and methods 
3.3.1 Ethics statement 
Inoculation of gilts or sows in the last trimester of gestation is a widely accepted and 
commonly used model for studying reproductive PRRS (Cheon and Chae 2001; Cano 2009; 
Rowland 2010; Karniychuk 2011; Han 2012; Karniychuk 2012). Although we recognize that 
some fetuses die after inoculation, death can occur unpredictably at any time after inoculation 
and no alternative models are available to study the reproductive effects of PRRSV infection. 
Monitoring fetal stress and discomfort is not feasible in a litter-bearing species like swine. Dams 
were monitored daily according to a humane intervention point (HIP) checklist developed 
specifically for this project as is presented in detail (S1 File). Animal numbers were carefully 
considered and the number of inoculated gilts was selected to enable both deep phenotyping and 
genotyping of gilts and fetuses. Gilts were housed in Biosecurity Level 2 rooms, 3 to 5 animals 
per room, in 2' x 7' gestation pens on perforated flooring. Room temperature was maintained at 
10-200 C using mechanically controlled ventilation, and gilts were individually fed a non-
medicated, commercial gestation diet once daily, and had ad libitum access to water. Given that 
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fetal death was an outcome, the experimental protocol was considered carefully before approval 
by the University of Saskatchewan’s Animal Research Ethics Board. It adhered to the Canadian 
Council on Animal Care guidelines for humane animal use (permit #20110102). 
3.3.2 Experimental procedures 
Detailed experimental protocol for this study has been published (Ladinig 2014d). 
Briefly, on gestation day 85±1, 114 PRRSV-naïve pregnant gilts, approximately 10 months of 
age, were intramuscularly and intranasally inoculated with PRRSV (105 TCID50 total dose, 
NVSL 97–7895, Gen Bank Accession No. AF325691) and 19 negative control pregnant gilts 
were similarly sham inoculated with the minimum essential medium. NVSL 97-7895 is highly 
abortifacient strain isolated from cases of severe reproductive failure by the Diagnostic Virology 
Unit of NVSL USDA/APHIS in a farm located in southeast Iowa in December 1996 (Allende 
2000). The decision to use this particular strain in the present study was based on the results of 
our pilot study during which NVSL 97-7895 demonstrated higher virulence than two other type 2 
strains (Ladinig 2015b). During the course of the present study, two gilts aborted, one died, but 
no other gilts demonstrated severe clinically illness as previously described in detail (Ladinig 
2014d). At 21days post inoculation (DPI), dams and their litters were humanely euthanized for 
necropsy examination. Gilts were sedated with intravenous barbiturate (30 mL Euthanyl Forte 
supplying 16,200 mg pentobarbital sodium, Vetoquinol, Lavaltrie, QC) and humanely euthanized 
by cranial captive bolt followed by pithing. The gilt reproductive tract was removed intact and 
opened starting at the tip of each horn. A sample of the uterus with adherent placental layers 
(herein; maternal-fetal interface (MFI)), 10 cm in circumference and surrounding the umbilical 
attachment was collected from each fetus. From this sample, a full thickness, 4 cm2 section was 
collected in 10% buffered formalin for histology, and a 0.5 cm2 section was snap frozen in liquid 
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nitrogen for PRRSV RNA quantification using an in-house quantitative real-time PCR assay 
(qRT-PCR) as previously described (Ladinig 2014d). The preservation status was assigned for 
each fetus (Ladinig 2014d) based on the external gross appearance of their skin and umbilical 
cord as: viable (normal, white to purple skin with visible hair and regular umbilical cord), 
meconium-stained (skin covered with inspissated, brownish amniotic fluid and regular umbilical 
cord with edema), decomposed (<50% of skin discoloured, no blood in the umbilical cord), 
autolysed (>50% of skin discoloured), and mummified fetuses (dehydrated and small with 
crown-rump length <20 cm). Fetal samples of lung, liver, heart, thymus, mesenteric lymph node 
and cerebellum were collected in 10% buffered formalin for histology. A section of fetal thymus 
was also snap frozen in liquid nitrogen for PRRSV RNA quantification by real-time qRT-PCR. 
Fetal samples for histopathology were not collected from autolyzed or mummified fetuses. 
The formalin fixed tissues were processed within 48 hours of collection, paraffin 
embedded, and 4μm microsections were hematoxylin and eosin (HE) stained. Upon removal 
from liquid nitrogen, snap frozen gilt and fetal tissue samples were stored at -80°C pending RNA 
extraction from 10–20 mg using the RNeasy extraction kit (Qiagen Inc., Toronto, ON) according 
to the manufacturer’s instructions. PRRSV RNA concentration was measured using an in-house 
probe-based real-time qRT-PCR as previously described (Ladinig 2014d). 
3.3.3 Histopathology 
Uterine and fetal samples (1452 infected and 231 negative controls) were assessed by 
pathologists (SED and PN) blinded to qRT-PCR results and inoculation status. Histopathological 
evaluation of the fetal organs, placenta, endometrium, myometrium, and umbilical cords was 
based on a qualitative (presence/absence) assessment of potentially significant pathological 
lesions associated with PRRSV. Assessment of fetal lesions included those previously described 
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such as segmental lymphoplasmacytic arteritis and periarteritis in heart and lung (Lager and 
Halbur 1996), interstitial pneumonia (Rossow 1998), periportal hepatitis, lymphoplasmacytic 
myocarditis with the loss of myocardial fibers, and leukoencephalitis particularly affecting 
cerebellum (Rossow 1996b). Also, fetal thymuses and mesenteric lymph nodes were assessed for 
previously described lesions such as thymic cortical atrophy and lymph node necrosis, polycystic 
degeneration, polykaryocytes, germinal center hypertrophy, and hyperplasia (Rossow 1994a; 
Rossow 1994b). Umbilical cords were evaluated for the presence of necrotizing umbilical 
arteritis and severe periarterial hemorrhage (Lager and Halbur 1996). Uterine tissues with fetal 
placentas were assessed for previously described lesions in the myometrium, endometrium and 
placenta such as lymphohistiocytic vasculitis, endometritis, and placental microseparations 
(Christianson 1993; Lager and Halbur 1996). 
3.3.4 Histologic grading  
A grading scheme was developed to score the endometrial inflammation, vasculitis 
severity, and vasculitis distribution. Only uterine tissue sections with fully attached fetal placenta 
were selected for grading of lesions (n=679 from 110 infected gilts). Endometrial inflammation 
was scored by assessing the total area of the endometrium tissue present on the microscope slide 
at 200X field of magnification. The inflammation in the endometrium was categorized as 
follows: grade 0 (normal) = very rare inflammatory cells present; grade 1 (minimal) = 
inflammatory cells multifocally present in < 10% of the tissue section; grade 2 (mild) = 
multifocal to coalescing inflammatory cell infiltrate in 10-25% of the tissue; grade 3 (moderate) 
= diffuse inflammatory cell infiltrate in 25-50% of the tissue, and grade 4 (severe) = 
inflammatory cells diffusely present in >50% of the tissue section.  
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To score vasculitis severity, three 200X microscopic fields of the endometrium per 
uterine tissue section were selected randomly by relocating the slide to a new field of view whilst 
withdrawing eyes from the eyepiece (ocular lenses). Within each of those three fields, three 
blood vessels (at 3, 9 and 12 o’clock in the field) were scored at 400X magnification as: grade 1 
= presence of inflammatory cells only within the blood vessel wall; grade 2 = presence of the 
inflammatory cells together with degeneration (vacuolation and splitting of smooth muscles) or 
necrosis of the blood vessel wall layers; grade 3 = presence of inflammatory cells together with 
degeneration and necrosis in the blood vessel wall layers. The nine individual vessel scores were 
averaged providing a single severity score per fetus.  
The vasculitis distribution score was adapted from the previous work (Cribier 1999; 
Gross 2000) and based on the distribution of vasculitis in the endometrium present in a 200X 
microscopic field as follows: grade 0 (normal) = no blood vessels affected; grade 1 = from 0 to 
<30% of vessels affected by vasculitis; grade 2 = from 30% to 70% of vessels affected by 
vasculitis and grade 3 = >70% of blood vessels affected by vasculitis in the tissue section.  
3.3.5 Statistical Analyses 
All statistical analyses were performed using two-level, mixed-effects regression models 
that controlled for litter of origin as a random effect (Stata 13, StataCorp LP, TX, USA). A 
mixed effects logistic regression model (MELOGIT) was used to assess potential relationships 
between fetal lesions (presence/absence) and vasculitis distribution score, average vasculitis 
severity score, endometrial inflammation score, and PRRSV RNA concentration (logarithm10 
target genomic copies/gram) in MFI and fetal thymus. MELOGIT was also used to assess 
potential relationships between fetal preservation status (viable/meconium-stained) and the 
presence of fetal lesions, umbilical lesions, distribution and severity of vasculitis and endometrial 
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inflammation. Separate unconditional mixed effects linear regression models (MIXED) were 
used to assess potential relationships between average vasculitis severity score and PRRSV RNA 
concentration in the uterus or fetal thymus. For these models, average vasculitis severity score 
was natural log (ln) transformed to ensure the model assumptions of linearity and homogeneity 
were not violated. Separate unconditional, proportional odds models (MEOLOGIT) were used to 
assess potential relationships between vasculitis distribution score and PRRSV RNA 
concentration in the uterus or fetal thymus. MEOLOGIT models were also used to assess 
relationships between endothelial inflammation score and PRRSV RNA concentration in uterus 
or thymus. Potential violation of proportional odds assumption was evaluated by comparing the 
coefficients with those generated with an equivalent generalized ordered logistical (GOLR) 
model in which the RNA concentration variable was unconstrained. In all cases, the proportional 
odds assumptions were not violated (coefficients were similar in both the PO and GOLR 
models), so results of the proportional odds models are reported herein. Finally, the potential 
association between endothelial inflammation score and vasculitis distribution and severity was 
assessed in a single proportional odds model that contained both vasculitis variables as fixed 
effects. To visualize statistically significant relationships between dependent and independent 
variables in proportional odds models, probability plots (GLLAPRED) were generated. For all 
models, litter of origin was included as a random effect and all models were verified for 
normality and homogeneity of residuals. Statistical significance was assigned at the P < 0.05 
level a priori.  
3.4  Results  
Of the 114 gilts PRRSV-inoculated, two aborted, 1 died, and 1 had all uterine tissue 
samples with completely detached fetal placentas. All were removed from the analyses. There 
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were 1452 fetuses from the remaining 110 PRRSV-infected gilts and 231 fetuses from the 19 
control gilts (total = 1683). Of these, tissues were not collected from 585 autolysed and 35 
mummified fetuses. Microscopic examination was performed on all available fetuses including 
1069 lungs, 1077 livers, 1080 hearts, 1037 thymuses, 983 mesenteric lymph nodes and 1072 
cerebella (Table 3.1). Some organs from some fetuses were inadvertently not collected. 
3.4.1 Histopathology of the fetus 
The most prevalent lesions in fetuses from infected gilts were observed in mesenteric 
lymph nodes and umbilical cords. In 11.4% of mesenteric lymph nodes, there was mild to 
moderate follicular atrophy with the replacement of lymphocytes by macrophages. In one fetus, 
multinucleated cells with cytological features resembling polykaryocytes were found. Rarely, 
fetal mesenteric lymph nodes demonstrated focal areas of lymphoid hyperplasia. Lesions in 5.9% 
of umbilical cords were characterized by focal to multifocal, mild lymphocytic perivascular 
cuffing. Occasionally, mild to moderate hemorrhage surrounding the umbilical arteries and vein 
was observed. For one fetus, there was diffuse and severe hemorrhage that markedly distended 
umbilicus. The presence of inflammatory cells in vessel walls (vasculitis) of the umbilical 
arteries or veins was not observed. In 3.2% of fetal hearts, there was mild, focal to multifocal, 
lymphocytic myocarditis and perivascular cuffing. Occasionally, myocardiocyte degeneration 
and necrosis were observed. In 2.5% of fetal livers, small infiltrates of lymphocytes were focally 
present in the portal areas (mild periportal hepatitis). In 2.2% of fetal cerebella, there was 
perivascular cuffing and gliosis. In one fetus, there was severe meningoencephalitis. In 1.3% of 
fetal lungs there was multifocal, mild thickening of the alveolar septa by small numbers of 
macrophages and lymphocytes (mild interstitial pneumonia). In 0.7% fetal thymuses mild to 
moderate atrophy was observed. No microscopic evidence of vasculitis was seen in any fetal 
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tissue and no microscopic lesions were found in tissues obtained from fetuses of negative control 
pregnant gilts. 
3.4.2 Histopathology of the maternal-fetal interface 
The most prevalent lesion observed at the MFI was a lymphohistiocytic endometritis, 
ranging from mild to severe. This was observed in 99.6% of PRRSV-infected MFI tissue 
samples (uterus with fetal placenta) corresponding to each fetus. Less prevalent were 
lymphocytic myometritis in 58.5% and lymphohistiocytic placentitis in 6.6% of PRRSV-infected 
gilts (Table 3.2). Most of the samples of MFI from the negative control gilts had no lesions. 
However, mild lymphocytic inflammation was observed in one myometrium (adjacent viable 
fetus without lesions) and two endometria (adjacent one viable fetus without fetal lesions, and 
one autolysed fetus) out of 230 negative control fetuses examined (Table 3.2). Vasculitis in the 
endometrium was primarily observed within the small caliber vessels, but occasionally arteries 
and veins were affected. The lymphocytes were found in all layers of the blood vessels, along 
with various degrees of degeneration of the tunica intima and media. Fibrinoid vascular 
degeneration was rarely observed.  
3.4.3 Relationship between fetal lesions and PRRSV RNA concentration  
The PRRSV RNA concentration (target copies/mg) was measured in fetal thymus and 
sections of MFI adjacent the umbilical stump of each fetus. Across all PRRSV-infected gilts and 
fetuses, the average PRRSV RNA concentration (log10 copies/mg) in the MFI and fetal thymus 
was 2.97 (±2.23) and 3.17 (±2.72), respectively. The proportion of the litter and MFI samples 
that tested PRRSV qRT-PCR positive were very similar (S1 Fig. and S2 Fig.). Of the 679 fetuses 
with fully attached fetal placenta that were used in the histological analyses below, the average 
PRRSV RNA concentration (log10 copies/mg) in MFI and fetal thymus was 3.32 (±2.36) and 
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3.05 (±3.22), respectively. One or more lesions were present in the tissues of 96 of 679 of fetuses 
(14%). Similarly, 95 of 679 fetuses (14%) were meconium stained in this dataset. The presence 
of fetal lesions was positively related to PRRSV RNA concentration in the maternal-fetal 
interface (odds ratio [OR], 1.4; 95% CI 1.2 to 1.6; P<0.001) as well as in the fetal thymus (OR, 
1.3; 95% CI 1.2 to 1.4; P<0.001). There was no significant relationship between the presence of 
fetal lesions and vasculitis distribution, vasculitis severity, or endometrial inflammation severity. 
The presence of fetal and umbilical lesions significantly increased the odds of a fetus being 
meconium stained compared to being viable (OR 2.1, 95% CI 1.1 to 4.1, P<0.05 for fetal lesions; 
OR 6.9, 95% CI 3.2 to 14.9, P<0.001 for umbilical lesions). However, fetal preservation status 
was not associated with vasculitis distribution or severity, or endometrial inflammation severity. 
3.4.4 Assessment of endometrial inflammation and vasculitis and relationship to viral load 
A total number of 679 uterine tissue sections from 110 PRRSV-infected pregnant gilts 
were scored for endometrial inflammation, vasculitis severity and vasculitis distribution (Figure 
3.1). Results revealed that 72.9% of the uterine tissues demonstrated moderate (grade 3) 
lymphohistiocytic endometritis, while minimal evidence of lymphohistiocytic endometritis was 
found in only 2.5% tissue sections (grade 1). We found that in 67.3% of the tissue sections the 
vasculitis affected <30% of vessels (grade 1), and only in 2.4% of tissue sections, the vasculitis 
affected more than 70% of blood vessels (grade 3). Regarding the severity of the vasculitis in the 
endometrium, we found that 62.8% of tissue sections demonstrated grade 1, 33.1% grade 2, and 
4.1% grade 3 severity score (Table 3.3). No evidence of vasculitis was found in 1.0% (7/679) of 
the endometrial tissues from PRRSV-infected pregnant gilts, and they were graded as normal 
(grade 0). Uterine tissue sections from the negative control gilts had no significant inflammatory 
lesions, and they were all graded as normal (grade 0).  
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There was no significant relationship between endometrial inflammation score and 
PRRSV RNA concentration in the uterus, and neither vasculitis distribution nor average 
vasculitis severity score was significantly related to PRRSV RNA concentration in the uterus or 
in fetal thymus. Endometrial inflammation severity was negatively related to PRRSV RNA 
concentration in the fetal thymus (P<0.05; Figure 3.2). Endometrial inflammation score was 
positively related to both vasculitis distribution (P<0.001) and severity of vasculitis in the 
endometrium (P<0.001; Figures 3.3 and 3.4).  
3.5  Discussion 
The present study is part of a large-scale reproductive PRRS project investigating the 
phenotypic and genotypic factors associated with viral load and fetal death. The decision to 
inoculate at 85 days of gestation was based on the results of previous studies that confirm that 
late gestation infection between 72 to 93 days consistently results in transplacental infection and 
reproductive failure that is similar to field observations (Karniychuk and Nauwynck 2013). 
While the decision to terminate at 21 DPI was potentially past peak viral load and acute-stage 
uterine histopathology, it was required to fulfill the overarching project objectives including the 
identification of factors associated with fetal death and viral load, and to advance the 
understanding of factors involved in the pathogenesis of fetal death. In spite of the single 
collection time point well past the acute stage in the dam, the present histopathological study 
enabled the unprecedented assessment of a large number of fetal and maternal tissues and 
determined potential relationships amongst lesions and viral load.   
The objectives of this present study were to evaluate the microscopic lesions in the 
uterus, placenta, and fetal tissues, histologically grade lesion severity associated with PRRSV 
infection at the maternal-fetal interface, and determine potential associations between severity of 
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lesions at maternal-fetal interface, fetal lesions, PRRSV viral load in the uterine tissue and the 
fetus, and fetal preservation status. 
The most prominent and consistent lesions were observed in the uterus and the fetal 
placenta while fetal histopathological lesions were less frequent and more variable in severity 
and histological presentation. The majority of uteri and fetal placental samples obtained from 
PRRSV-infected pregnant gilts demonstrated significant inflammatory lesions affecting mostly 
endometrium, fetal placenta, and blood vessels. Furthermore, when severity and distribution of 
inflammation lesions were histologically graded the majority of uterine tissue samples exhibited 
moderate (73%) or severe (10%) lymphohistiocytic endometritis, and almost one-third of 
samples demonstrated severe vasculitis in more than 30% of blood vessels. These findings 
indicate that inflammation in the uterus, fetal placenta, and endometrial blood vessels are the 
most prominent pathological characteristics of type 2 PRRSV infection in pregnant gilts at 21 
days post inoculation. This finding is also in agreement with previously published studies (Lager 
and Halbur 1996). In the present study, we found a significant relationship between the 
distribution and the severity of the vasculitis in the lamina propria, and the severity of 
endometrial inflammation in the uterus. This finding supports the important role of endometrial 
blood vessels in PRRSV transmission into the uterus of viremic pregnant gilts. The exact 
mechanism of transplacental viral transmission is still unknown, but it has been hypothesized 
that it is mediated either by the infection of blood monocytes (Karniychuk and Nauwynck 2013) 
and/or endothelial cell of the endometrial blood vessels (Halbur 1995). However, there was no 
significant relationship between the concentration of PRRSV RNA in the maternal-fetal interface 
and the severity of endometrial inflammation or the distribution and severity of endometrial 
vasculitis. Also, no significant association was found between the concentration of PRRSV RNA 
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in the fetal thymus and the distribution and severity of endometrial vasculitis. A statistically 
significant negative relationship between endometrial inflammation and PRRSV RNA 
concentration in fetal thymus was, in our opinion, most likely related to collecting samples at 21 
DPI in our study. It is known that viremia in the sows and postnatally infected pigs reaches peak 
at 7-9 days post inoculation. However, the duration of viremia and presence of PRRSV in the 
fetus or congenitally infected pigs is slightly longer (Rowland 2003). The reason for the longer 
viremia in the fetus is due to PRRSV replication in the primary lymphoid organs such as thymus 
(Cheon and Chae 2001). It is possible that the severity of endometrial inflammation in some 
infected gilts had started to subside before 21 DPI, while PRRSV in fetus continued to replicate 
unabated until termination. However, the statistically significant relationship between PRRSV 
RNA concentration in the fetal thymus and the severity of endometrial inflammation found in 
this study (Figure 3.2) may be too weak to be biologically relevant based on the value of the 
regression coefficient (β=0.08).  
The most important finding in this study was a significant, positive relationship between 
the presence of fetal lesions and PRRSV RNA concentration, both in the MFI and the fetal 
thymus. In other words, the odds of a fetus having PRRSV-associated lesions increased as did  
PRRSV viral load in both tissues. Even more, meconium staining, an early sign of fetal 
compromise, was significantly associated with the presence of histological fetal and umbilical 
lesions. In this study, we determined that fetuses with umbilical lesions were seven times more 
likely to be meconium stained than those fetuses without lesional cords. Fetuses with lymphoid 
and/or systemic lesions were two times more likely to be meconium stained than fetuses without 
these lesions. These results revealed that not only umbilical lesions as previously suspected 
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(Lager and Halbur 1996) but also fetal lesions, play a significant role in the pathogenesis of fetal 
demise following type 2 in utero PRRSV infection.  
In retrospect, the ability to quantify viral load in the maternal (endometrium) and fetal 
(adherent placenta) portions of the MFI would have been very beneficial, but it was not possible 
based on the volume of samples processed on a given sample collection day. That being said, 
pathological processes observed at 21 DPI at the MFI have no significant relationship on the 
occurrence of fetal lesions or fetal preservation status, likely because the inflammatory process is 
well past its peak by this time. As these results are in contradiction with some previous reports 
(Karniychuk 2011; Karniychuk and Nauwynck 2013) that suggested that fetal death in the 
reproductive PRRSV infection is primarily a consequence of the pathological processes at the 
MFI and not in the fetus itself, we have additional experiments planned using early termination 
points to help clarify this issue. However, our present results indicate that pathological processes 
associated with fetuses are essential predictors of the fetal preservation status. This finding is in 
accordance with some of the most recent studies indicating that presence of PRRSV in fetuses, 
particularly in the thymus, increased the likelihood of fetal death (Ladinig 2015a). 
3.6  Conclusions 
This large-scale, multicenter, challenge experiment enabled an extensive evaluation of fetal and 
uterine lesions caused by type 2 PRRSV infection in third-trimester pregnant gilts at 21 DPI, and 
provided new insights into the pathogenesis of fetal death. Severe microscopic lesions were 
observed in the uterus and fetal placenta, but not in the fetus. Lymphohistiocytic endometritis 
and lymphocytic myometritis were observed in nearly 100% and 60% of uterine samples, 
respectively, whereas the most common fetal lesions, follicular atrophy of mesenteric lymph 
nodes and lymphocytic perivascular cuffing in umbilical vessels, were markedly less prevalent. 
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The presence of fetal lesions was positively associated with PRRSV viral load in the uterus and 
fetal thymus, but not with severity of uterine pathology. Moreover, the presence of fetal and 
umbilical lesions, but not uterine pathology, increased the likelihood of fetal meconium staining. 
While the distribution and severity of inflammation in endometrial blood vessels were positively 
associated with inflammation in the lamina propria, the severity and distribution of vasculitis, 
and severity of endometrial inflammation were not associated with PRRSV RNA concentration 
at the maternal-fetal interface or in fetal thymus at 21 DPI. The overall conclusion of this study is 
that although type 2 PRRSV infection in pregnant gilts induces significant pathological lesions at 
the maternal-fetal interface, fetal and umbilical pathology and PRRSV viral load all likely 
contribute to fetal compromise and death.  
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Table 3.1. Numbers of fetal tissues with histopathological lesions in type 2 PRRSV-infected and 
negative control pregnant gilts inoculated at gestation day 85 (± 1d). 
                    Fetal tissues  
  
Lung 
 
Liver 
 
Heart 
 
Thymus 
 
Mesenteric 
Lymph 
Node 
 
Cerebellum 
 
 
 
Umbilical 
cord 
 
Negative 
control  
 
0/221* 
 
0/223 
 
0/224 
 
0/222 
 
0/204 
 
0/224 
 
1/228 
 
PRRSV-
infected  
 
11/848  
 
21/854 
 
27/856 
 
6/815 
 
89/779 
 
19/848 
 
78/1321 
* Number of tissues with lesions/number of tissues examined. 
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Table 3.2. Number of uterine and placental tissues demonstrating histopathological lesions in 
type 2 PRRSV-infected and negative control pregnant gilts inoculated at gestation day 85 (± 1d).  
                             Uterus 
     Myometrium Endometrium Placenta 
Negative control  1/230* 2/230 0/230 
 
PRRSV-infected  822/1404 1399/1404 91/1360 
* Number of tissues with lesions/number of tissues examined. One section of maternal fetal 
interface (uterus with adherent fetal trophoblast) was collected at the umbilical stump of each 
fetuses examined. 
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Table 3.3. Numbers of uterine tissue sections scored for endometrial inflammation, distribution 
of vasculitis and severity of vasculitis distribution. 
                    Uterine tissues  
  
           Grade 0                                
 
Grade 1   
 
Grade 2 
 
Grade 3 
 
Grade 4 
 
Endometritis inflammation 
score  
 
  0/679*           
 
17/679           
 
97/679 
 
495/679 
 
70/679 
 
Vasculitis distribution 
score 
 
  7/679 
 
457/679 
 
199/679 
 
16/679  
 
0 
Severity vasculitis score 157/679 269/679 225/679 28/679  0 
* Number of tissues with score/number of tissues examined.  
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Figure 3.1. Histologic scores of endometrial inflammation and severity of vasculitis. 
(a) Uterus, endometrium, lamina propria; PRRSV-infected pregnant gilt; Hematoxylin and Eosin 
(HE). Minimal lymphohistiocytic endometritis (grade 1.). (b) Uterus, endometrium, lamina 
propria; PRRSV-infected pregnant gilt; HE. Mild lymphohistiocytic endometritis (grade 2.). (c) 
Uterus, endometrium, lamina propria; PRRSV-infected pregnant gilt; HE. Moderate 
lymphohistiocytic endometritis (grade 3.). (d) Uterus, endometrium, lamina propria; PRRSV-
infected pregnant gilt; HE. Severe lymphohistiocytic endometritis (grade 4.) (Scale bar = 200 
μm). (e) Uterus, endometrium, blood vessel; PRRSV-infected pregnant gilt; HE. Lymphocytic 
vasculitis (severity grade 1.) (arrow). (f) Uterus, endometrium, blood vessel; PRRSV-infected 
pregnant gilt; HE. Lymphocytic vasculitis with vacuolar degeneration of the cells in the tunica 
intima (severity grade 2.) (arrowhead). (g) Uterus, endometrium, blood vessel; PRRSV-infected 
pregnant gilt; HE. Severe lymphocytic vasculitis with necrosis (severity grade 3.) (asterisk) 
(Scale bar = 200 μm). 
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Figure 3.2. Relationship between endometrial inflammation and PRRSV RNA concentration 
(log10/gram) in fetal thymus.  
Endometrial inflammation severity is indicated by 4 coloured lines: minimal (green) = 
inflammatory cells multifocally present in < 10% of the tissue section; mild (blue) = multifocal 
to coalescing inflammatory cells infiltrate in 10-25% of the tissue; moderate (red) = diffuse 
inflammatory cell infiltrate in 25-50% of the tissue; severe (black) = inflammatory cells diffusely 
present in >50% of the tissue section. Results indicate increased viral load in fetal thymus is 
associated with decreased probability of moderate and severe endometrial inflammation 
observed at 21 DPI. 
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Figure 3.3. Relationship between endometrial inflammation and severity of vasculitis.  
Endometrial inflammation severity is indicated by 4 colored lines: minimal (green) = 
inflammatory cells multifocally present in < 10% of the tissue section; mild (blue) = multifocal 
to coalescing inflammatory cells infiltrate in 10-25% of the tissue; moderate (red) = diffuse 
inflammatory cell infiltrate in 25-50% of the tissue; severe (black) = inflammatory cells diffusely 
present in >50% of the tissue section. Results indicate the probability of observing severe 
endometrial inflammation at 21 DPI increases with vasculitis severity. 
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Figure 3.4. Relationship between endometrial inflammation and distribution of vasculitis.  
Endometrial inflammation severity is indicated by 4 coloured lines: minimal (green) = 
inflammatory cells multifocally present in < 10% of the tissue section; mild (blue) = multifocal 
to coalescing inflammatory cells infiltrate in 10-25% of the tissue; moderate (red) = diffuse 
inflammatory cell infiltrate in 25-50% of the tissue; severe (black) = inflammatory cells diffusely 
present in >50% of the tissue section. Results indicate the probability of observing severe 
endometrial inflammation at 21 DPI increases with more extensive vasculitis distribution. 
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4 Relationships of CD163 and CD169 positive cell numbers in the endometrium and fetal 
placenta with type 2 PRRSV RNA concentration in fetal thymus 
 
In chapter 3, we confirmed significant pathological lesions affecting MFI of PRRSV-infected 
pregnant gilts. This chapter represents immunohistochemical detection and assessment of the 
numbers of PRRSV, CD163, CD169 positive cells, and cathepsin positive areolae at the MFI, 
and evaluation of their potential relationship with PRRSV viral load in the MFI and fetal thymus. 
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4.1  Abstract  
The pathogenesis of transplacental infection associated with porcine reproductive and 
respiratory virus (PRRSV) is still poorly understood. Several routes of PRRSV transmission 
across the porcine intact diffuse epitheliochorial placentation have been proposed, but none have 
been proven. The objectives of this study were to investigate associations between numbers of 
CD163 and CD169 positive macrophages, cathepsin positive areolae, and PRRSV load at the 
maternal-fetal interface in order to examine important factors of PRRSV transplacental 
transmission. On gestation day 85±1, naïve pregnant gilts were inoculated with PRRSV (n=114) 
or were sham inoculated (n=19). At 21 days post-inoculation, dams and their litters were 
humanely euthanized and necropsied. Samples of the maternal-fetal interface (uterus with fully 
attached placenta) and fetal thymus were collected for analysis by RT-qPCR to quantify PRRSV 
RNA concentration. The corresponding paraffin-embedded uterine tissue sections were subjected 
to immunohistochemistry for PRRSV nucleocapsid N protein, CD163, CD169, and cathepsin. 
Our findings confirm significant increases in the numbers of PRRSV, CD163 and CD169 
positive cells at the maternal-fetal interface during type 2 PRRSV infection in pregnant gilts. An 
increase in the ratio of CD163+ cells in endometrium versus placenta was associated with an 
increase in PRRSV load in fetal thymus, and a decrease in odds of the fetus being PRRSV-
negative. This finding suggests an important role for placental CD163+ cells during trans-
placental PRRSV transmission.   
 
Key words: PRRSV, uterus, placenta, CD163, CD169, areolae, cathepsin-L 
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4.2  Introduction 
Porcine reproductive and respiratory syndrome (PRRS) continues to be the most costly 
disease of the North American swine industry resulting in economic losses estimated to be $664 
million annually (Holtkamp 2013). PRRS is caused by an enveloped positive-stranded RNA 
virus, in the genus of Arterivirus and family Arteriviridae (Done 1996; Rossow 1998; 
Zimmerman 2012). Viral replication of porcine reproductive and respiratory syndrome virus 
(PRRSV) initially occurs in local permissive macrophages and then rapidly spreads to well-
differentiated monocyte-derived cells, such as pulmonary alveolar macrophages (PAM), 
intravascular macrophages (PIM) in the lung (Thanawongnuwech 1997a; Thanawongnuwech 
2000a; Delputte and Nauwynck 2004), and macrophages in lymphoid tissue (Rossow 1998). 
Two markers identified on the surface of permissive macrophages are CD163 entry 
mediator and sialoadhesin (CD169) receptor (Van Gorp 2008). CD163 is a glycosylated 
membrane protein expressed almost exclusively on macrophages and monocytes (Møller 2012). 
As a macrophage scavenger receptor, CD163 is involved in taking up haptoglobin-hemoglobin 
complexes, erythroblast adhesion, innate immunity of bacteria, and binding of TNF-like inducers 
of apoptosis (Møller 2012). CD163 is an essential receptor for the entry and uncoating of 
PRRSV from the early endosomes of permissive cells (Zhang and Yoo 2015).  
Attachment of PRRSV to target cells is believed to occur through the interaction of the 
viral ligand GP5 and M heterodimer complex with CD169 receptor (Vanderheijden 2003; Zhang 
and Yoo 2015). CD169 receptors belong to the family of sialic acid-binding immunoglobulin-
like lectins that are expressed on specific subsets of tissue macrophages found in the spleen, 
lymph nodes, bone marrow, liver, colon, and lungs (Hartnell 2001). Previously, CD169 was 
reported to be involved in the attachment and internalization of viruses (Delputte and Nauwynck 
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2004) and bacteria (Jones 2003), but recent studies with porcine CD169 suggest its role as an 
endocytic receptor in targeted delivery of toxins and antigens to macrophages (Delputte 2011).  
Both CD169 and CD163 have been shown to be required for type 1 PRRSV infection in 
vitro (Van Gorp 2008). It has also been demonstrated that both CD169 and CD163 positive 
macrophages are increased within the implantation sites and organs of porcine embryos and 
fetuses during gestation (Karniychuk and Nauwynck 2009). However, CD169 negative 
transgenic pigs infected with type 2 PRRSV have demonstrated no difference in virus replication 
compared to infected wildtype pigs (Prather 2013), while CD163 negative transgenic pigs did not 
develop type 2 PRRSV infection (Whitworth 2016). Experiments with type 1 PRRSV infection 
of pregnant sows have confirmed that all PRRSV-infected cells at the maternal-fetal interface 
were also CD163 and CD169 positive (Karniychuk 2011).    
While CD163 and CD169 macrophages have been explored, other potential mechanisms 
of transplacental infection of PRRSV have been largely uninvestigated. In pigs, the 
transplacental exchange of gases, micronutrients and macromolecules is accomplished by 
maternal hematotrophic and histotrophic nourishment of the fetus. Histotroph is a source of 
nutrition for the fetus provided by secretions of uterine epithelia in the dome-shaped structures 
over the openings of uterine glands called areolae (Bazer and Johnson 2014). In the areolae, 
secretions from superficial and deep uterine glandular epithelium, and selective transudation 
from maternal serum are absorbed and transported across the chorioallantois by fluid phase 
pinocytosis into the fetal circulation (Friess 1981). During gestation, lysosomal cysteine protease 
cathepsin-L, is highly expressed in the chorionic epithelium of the areolae (Song 2010). 
Therefore, a potential site of trans-placental infection may be areolae. 
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Recent studies revealed a significant association between type 1 PRRSV infection and the 
numbers of CD169 positive cells in the maternal-fetal interface (MFI) (Karniychuk 2013). 
Additionally, results of our histopathological evaluation of type 2 PRRSV infection in pregnant 
gilts in the third trimester of pregnancy confirmed marked inflammatory changes at MFI 
(Novakovic 2016a) suggesting potential cell-associated PRRSV transmission from the mother to 
the fetus (Karniychuk and Nauwynck 2013). In order to further test this hypothesis, we 
developed two objectives for the present study. The first objective was to evaluate the numbers 
of PRRSV, CD163 and CD169 positive cells in the endometrium and fetal placenta, and to test if 
the numbers of cathepsin positive areolae at the MFI differed between groups selected on the 
basis of PRRSV viral load (negative, low, high). The second objective was to assess the 
relationship between PRRSV viral load in the fetal thymus compared to the numbers of CD163 
and CD169 positive cells in the endometrium and fetal placenta, and cathepsin positive areolae at 
the MFI.    
4.3 Material and Methods 
4.3.1 Experimental design and selection of samples 
The animal use protocol was reviewed and approved by the Animal Research Ethics 
Board (AREB) at the University of Saskatchewan and followed the principles established by the 
Canadian Council on Animal Care (permit #20110102). The experimental protocol for this study 
has been described in detail (Ladinig 2014d). Briefly, on 85±1 gestation day, 114 PRRSV-naïve 
pregnant gilts were intramuscularly and intranasally inoculated with PRRSV (1 × 105 TCID50 
total dose, NVSL 97–7895, Gen Bank Accession No. AF325691) and 19 negative control 
pregnant gilts were sham inoculated with minimum essential medium (Life Technologies, 
Burlington, Canada). At 21days post-inoculation (DPI), dams and their litters were humanely 
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euthanized for necropsy examination. Samples of fetal thymus and MFI (endometrium with 
adherent placental layers) adjacent to the umbilical stump of each fetus were collected for 
histology and an in-house quantitative RT-PCR analysis of PRRSV RNA concentration, as 
previously described (Ladinig 2014d). From a total of 679 available MFI samples collected from 
live fetuses with intact uterine-placental tissue, 120 paraffin-embedded MFI samples were 
selected, based on the PRRSV RNA concentration in the MFI, for PRRSV, CD163, CD169, and 
cathepsin immunohistochemistry (IHC).  
Three viral load groups were designated negative, low and high. Negative samples were 
RT-qPCR negative samples from non-infected gilts (mean 0.7 ±0.8 sd; n=40). Low viral load 
samples from infected gilts had PRRSV RNA concentration less than 2.3 log10 copies per mg 
MFI (mean 5.2 ±1.2 sd; n=40). High viral load samples from infected gilts had PRRSV RNA 
concentration greater than 2.8 log10 copies per mg MFI (n=40). PRRSV RNA concentration in 
the low and high viral load groups averaged 0.7 ± 0.8 and 5.2 ± 1.2 log10 copies/mg, 
respectively. The low and high samples were matched pairs from 40 infected gilts. The negative 
samples came from five gilts, eight samples per gilt. 
4.3.2 PRRSV Immunohistochemistry 
Five-micrometer tissue sections were prepared for IHC using proteinase K (Dako, 
Carpinteria, USA) antigen retrieval and Background Punisher blocking reagent (Biocare 
Medical, Concord, USA). The wash buffer was 0.05M Tris-buffered saline (Sigma-Aldrich, 
Oakville, Canada), pH 7.6 with 0.05% Tween-20 (TBST; Fisher Scientific, Markham, Canada). 
Primary monoclonal antibody against PRRSV nucleocapsid N protein (SDOW17, Rural 
Technologies Inc., Brookings, USA) was diluted 1:200 in antibody diluent (Dako) and placed on 
tissue sections overnight at 4oC in a humidified chamber. Envision+System-HRP (Dako) anti-
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mouse secondary antibody containing 2% normal swine serum (Life Technologies) was applied 
to sections for 45 min at RT. The signal was revealed using 3-Amino-9-Ethylcarbazole (AEC) 
chromogen (Dako) for 15 min and sections were counterstained with Mayer’s hematoxylin 
(Fisher Scientific). Coverslips were applied to slides using Glycergel (Dako) mounting medium. 
Negative controls consisted of uterine tissues obtained from non-infected gilts. 
4.3.3 CD163, CD169 and Cathepsin Immunohistochemistry 
IHC for CD163 and CD169 was performed as previously described (Lau 2004; Detmer 
2013) using rabbit polyclonal antibodies directed against human CD163 at dilution 1:100 
(ab87099, Abcam, Toronto, Canada) and mouse monoclonal antibodies directed against human 
CD169 (clone HSn 7D2) at dilution 1:50 (NB600-534, Novus Biologicals, Oakville, Canada). 
IHC for cathepsin was performed using mouse monoclonal antibodies directed against human 
cathepsin L + V at dilution 1:100 (ab6314, Abcam). Antigen retrieval was performed in 10mM 
citrate buffer (pH 6.0) at 100°C for 10 min. Using a Dako Automated Immunostainer and TBST 
for washing buffer, the antigen signals were amplified using Envision+System-HRP with 2% 
normal swine serum for 45 minutes and AEC chromogen for 10 min. Slides were counterstained 
with Mayer’s hematoxylin. Pig fetal lung and lymph node were used for the positive controls for 
CD163 and CD169 IHC. A normal pig uterus with placenta was used for the cathepsin positive 
control. Normal rabbit serum was used in place of primary antisera for the negative control. 
4.3.4 Image Analysis 
Quantitative analyses of immunohistochemical staining for PRRSV, CD163, CD169, and 
cathepsin positive areolae were performed using Image-Pro Plus version 7 software (Media 
Cybernetics, Inc., Rockville, USA). Ten microscopic fields of the endometrium, captured using a 
20X microscope objective lens, each representing 1 mm2 area (10 mm2 total/slide) were 
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randomly selected from each image of the uterine-placental tissue. Thereafter, multiple 
polygonal fields of fetal placenta comprising 3 to 4 mm2 in total were randomly selected from 
the same image at the same magnification. Inside these chosen fields, the total numbers of 
PRRSV, CD163 and CD169 immunopositive cells were manually counted. The total number of 
areolae was determined by manually counting the regions of cathepsin immunopositive staining 
across the entire maternal-fetal interface. All counts were expressed as a number per 1 mm2 area 
for statistical analyses. 
4.3.5 Statistical Analysis 
Separate statistical analyses were performed for each of the objectives of this study using 
Stata 13 (StataCorp LP, College Station, USA). To determine if numbers of CD163 and CD169 
positive macrophages and cathepsin positive areolae in the endometrium and fetal placenta 
differed among PRRS viral load groups (negative, low, high), separate two-level, linear mixed-
effects regression models were developed. For these models, numbers of CD163 and CD169 
positive macrophages in the endometrium and fetal placenta were zero-skewness log (lnskew0) 
transformed to ensure that model assumptions of linearity and homogeneity were not violated. 
Secondly, the potential relationships among numbers of CD163 and CD169 positive 
macrophages in the endometrium and the fetal placenta, numbers of cathepsin positive areolae at 
the MFI, and PRRS viral load in the fetal thymus were determined by using a two-level, zero-
inflated Poisson regression model. For this model, PRRSV RNA concentration in fetal thymus 
(per mg) was converted into a count variable, with each successive count representing a one log10 
increase in RNA concentration. Based on these results, the relationship between viral load in 
fetal thymus and the numbers of CD163+ and CD169+ macrophages in endometrium and fetal 
placenta was further explored using a single level proportional odds model (a two-level model 
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was not required) for which PRRSV RNA concentration in fetal thymus was categorized as 
negative (not detected), low (0 < log10 copies per mg < 5) and high (log10 copies per mg ≥ 5), and 
new variables representing the ratio of CD163+endo:CD163
+
plc and CD169
+
endo:CD169
+
plc were 
created. For this, only fetuses from PRRSV infected gilts were included. All two-level models 
accounted for clustering by litter of origin by including gilt as a random effect. Linear mixed 
models were assessed for normality and homogeneity of residuals. The proportional odds model 
was assessed for non-violation of the proportional odds assumption using the Brant test. Count 
models were assessed by evaluating how well the models predicted raw data, and where possible, 
evaluating the degree of over-dispersion. P value was deemed significant at 0.05 a priori. 
4.4 Results 
4.4.1 Distribution of immunopositive cells within the maternal-fetal interface 
PRRSV immunopositive cells were detected in all sections of MFI obtained from PRRSV 
infected gilts. The majority of samples demonstrated strong PRRSV immunopositivity of cells 
located primarily at the endometrial placental junction (mean 8.6 ± 10.8 cells per mm2). PRRSV 
immunopositive cells at these histological sites were closely associated with inflammatory cell 
infiltrates and had cytological features suggestive of tissue macrophages. Occasionally PRRSV 
antigen was clearly present in the uterine superficial glandular epithelial cells of the areolae 
(Figure 4.1A). In the endometrium, PRRSV immunopositive macrophages were rare and located 
away from blood vessels in the lamina propria (mean 1.7 ± 2.2 cells per mm2) (Figure 4.1B). 
Additionally, a remarkable finding in the endometrium was strong, albeit occasional, PRRSV 
immunopositive staining of epithelial cells of uterine glands. Rare PRRSV-infected macrophages 
were found in the fetal placenta residing in proximity to the MFI of PRRSV-infected gilts. 
PRRSV-infected cells were not detected in the MFI of sham inoculated gilts. 
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IHC for CD163 and CD169 revealed the largest number of CD163 immunopositive 
macrophage-like cells (mean 212.3 ± 82.6 per mm2) resided in the fetal placenta in close 
proximity to maternal and fetal microvilli interdigitation (Figure 4.1C), while the number of 
CD169 immunopositive cells observed in the fetal placenta were significantly lower (mean 69.8 
± 71.6 per mm2). In the endometrium, markedly lower numbers of CD163 immunopositive cells 
(mean 34.2 ± 27.2 per mm2) and CD169 immunopositive cells (mean 15.6 ± 15.7 per mm2) were 
observed multifocally in the lamina propria, occasionally in the blood vessel walls, and always 
interspersed throughout inflammatory cell infiltrate (Figures 4.1D and 4.1E). IHC of cathepsin 
revealed strong positive cytoplasmic staining of collections of trophoblastic cells forming 
distinct placental structures at the maternal-fetal interface most consistent with areolae (Figure 
4.1F). Regardless of the infection status of pregnant gilts, numbers of areolae counted at the MFI 
of each uterine tissue section were relatively stable (mean 3.5 ± 1.9). 
4.4.2 Relationship of cell counts to viral load 
Statistical analyses of the results of IHC experiments revealed significantly higher 
numbers of immunopositive cells in the endometrium and fetal placenta obtained from PRRSV 
infected gilts than negative control gilts for all markers, except for the numbers of CD163 
positive cells in the fetal placenta (Figures 4.2A-C). Additionally, statistical differences were 
found when low and high viral load groups were compared in terms of the numbers of PRRSV-
infected cells present in the endometrium and the fetal placenta at the MFI (P<0.05) (Figure 
4.2A). High PRRSV load group was characterized by significantly higher numbers of CD163 
positive cells in the endometrium, compared to the low PRRSV load group (Figure 4.2B). No 
significant differences were found in the numbers of CD169+ cells in the endometrium and fetal 
placenta between low and high PRRSV load groups (Figure 4.2C). Numbers of cathepsin-L 
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immunostained areolae across the MFI were also not statistically different between PRRS viral 
load groups. 
The numbers of CD163+ and CD169+ macrophages in the endometrium and fetal placenta 
and cathepsin positive areolae were assessed as potential predictors of PRRSV viral load in fetal 
thymus. After a backwards-stepwise elimination, only numbers of CD163+ macrophages in 
endometrium and fetal placenta were related to PRRS viral load in the fetal thymus (P=0.01). 
More specifically, increased PRRSV RNA concentration (log10 copies/mg) in the fetal thymus 
was associated with increased numbers of CD163+ macrophages in the endometrium and 
decreased numbers of CD163 macrophages in placenta (Table 1). In the proportional odds model 
used to further explore these relationships, viral load in fetal thymus (categorized as negative, 
low and high) was found to be very strongly related to CD163+endo:CD163
+
plc ratio (coef 7.1 
±2.1, 95% CI: 3.1, 11.2; P=0.001) (Figure 4.3). In fact, all fetuses with thymic PRRSV RNA 
concentration less than 6 log10 copies per mg had ratios less than 0.4 (Figure 4.4).  
4.5 Discussion 
The goal of this study was to evaluate the associations between the numbers of CD163 
and CD169 positive cells in the endometrium and fetal placenta, cathepsin positive areolae at the 
MFI, and PRRSV viral load in the MFI and fetal thymus. These results provide improved 
insights into the events occurring at the maternal-fetal interface during type 2 PRRSV infection 
and help to clarify the pathogenesis of PRRSV transplacental infection and induced reproductive 
failure. Previous studies (Lager and Halbur 1996; Rossow 1996b) as well as our observations in 
a related histopathology study of type 2 PRRSV infection in pregnant gilts (Novakovic 2016a) 
confirmed that type 2 PRRSV infection causes significant microscopic lesions in the uterus and 
fetal placenta at the maternal-fetal interface. Consequently, we hypothesized that in addition to 
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factors such as CD169 positive cells, in utero infection is influenced by other susceptible cell 
populations at the MFI.  
The findings of our first objective confirmed that there was a significant increase in the 
numbers of CD163+ and CD169+ macrophages in the endometrium and the fetal placenta in 
PRRSV-infected versus non-infected pregnant gilts. This finding was not unexpected because 
large numbers of these cells represent a significant portion of the cellular infiltrate in the highly 
inflamed areas of lamina propria suggesting a role in the innate immune response to PRRSV 
infection. On the other hand, differences in these cell numbers were much less consistent when 
the low and high PRRSV groups were compared. For example, only the numbers of CD163+ 
cells in endometrium were significantly increased in high versus low viral load groups. 
Nevertheless, this inconsistent relationship between cell counts and viral load reported herein is 
in the agreement with the results of our previously reported PRRS histopathologic evaluation 
(Novakovic 2016a) in which it was demonstrated that the severity of endometrial inflammation 
was not associated with PRRSV viral load in the uterus at 21 DPI.  
Not only did cell counts in fetal placenta not differ between high and low PRRS viral 
load groups, they markedly diverged from the results obtained from the endometrium. In 
particular, this applied to the numbers of CD163+ cells in placenta, which did not significantly 
differ in non-infected gilts compared to gilts with high PRRS viral load at the MFI. A possible 
explanation for this finding could be the presence of a residential population of fetal tissue 
macrophages, which in human placenta are known as Hofbauer cells. This population of 
histiocytes found in human villous mesenchyme and amniochorion on the fetal side of the 
uteroplacental unit is relatively constant, and can constitute nearly all macrophages in this region 
(Bulmer and Johnson 1984). It is believed these macrophages are involved in the prevention of 
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the transmission of the pathogens from the mother to the fetus (vertical transmission) and early 
placental development (Tang 2011). Importantly, Hofbauer cells strongly express CD163, CD68, 
and CD206 (Joerink 2011; Tang 2011; Sivakumar 2013).  
The presence of Hofbauer cells in the porcine fetal chorioallantois has not been reported 
to date, but in this present study, we observed large numbers of histiocytes with cytological 
features resembling Hofbauer cells and expressing strong cytoplasmic CD163 immunopositivity 
residing along the chorionic villi of the fetal placenta in both infected and non-infected gilts. 
Moreover, the number of CD163+ cells in placenta was negatively associated with viral load in 
fetal thymus, and increased numbers were significantly related to increased odds of a fetus being 
virus negative. This finding implies that CD163+ tissue macrophages in the placenta have a 
potentially significant role in transplacental PRRSV transmission. While numbers of CD163+ 
tissue macrophages in the endometrium are concomitant with uterine viral load, the numbers of 
CD163 positive cells in the fetal placenta might decrease subsequent to transplacental PRRSV 
infection.  
To explore this potential dichotomy further, we assessed the relationship between viral 
load in fetal thymus and the ratio of CD163+ cells present in endometrium and fetal placental 
(CD163endo:CD163plc), based on our hypothesis that a high ratio (reflecting increased 
macrophage numbers and infection pressure in uterus and low placental immune surveillance) 
would be associated with high fetal viral load. As anticipated, viral load in fetal thymus 
increased very substantially as the CD163+ endo:plc ratio increased. In addition, the odds of fetal 
thymus being PRRSV virus negative decreased dramatically in a nearly linear manner as 
CD163endo:CD163plc increased (Figure 4.3). Thus, large numbers of CD163
+ macrophages in 
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placenta, particularly in the presence of low CD163+ macrophages in the endometrium, may 
represent an exciting, yet unexplored mechanism of PRRSV resistance in late gestation fetuses.  
However, in order to draw this conclusion, at least one criterion would have to be met 
which is that porcine analogs of Hofbauer cells at the fetal placenta are not susceptible to 
PRRSV infection and subsequent viral replication. Unfortunately, current knowledge on the 
properties of this cell population regarding the PRRSV susceptibility is poor; therefore, future 
studies in this area are highly warranted. On the other hand, fetal placenta (chorioallantois) is 
confirmed to be highly susceptible to type 1 PRRSV infection demonstrating markedly larger 
numbers of PRRSV-positive cells than the endometrium at 10 DPI (Karniychuk 2011). Although 
type 1 and type 2 PRRS viruses are genetically distinct with differences in pathogenicity in vitro 
and in vivo (Choi 2015), it can be hypothesized that by collecting the fetal placenta 21 DPI in our 
study we detected a decrease in the numbers of CD163 positive cells as a result of the cytopathic 
effect of PRRSV on a highly susceptible population of cells. Furthermore, this finding could 
suggest that instead of a protective role, placental CD163+ cells may play a role in transplacental 
infection of the fetus or in viral replication in the fetal compartment following infection. In other 
words, once PRRSV transmits transplacentally, the resident CD163 positive cells become “fertile 
soil” for viral propagation and spread to the fetal organs. Therefore, it is essential to conduct 
future studies aimed at determining the susceptibility of porcine placental macrophages to 
PRRSV infection.       
Unlike for the CD163+ cells, there was no significant difference between high and low 
viral groups. Only a difference between infected and uninfected was statistically significant for 
CD169 and both cell types demonstrated an increase in the endometrium and placenta with 
infection. A few previously published reports indicate the importance of CD169 as a receptor 
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mediating cell entry for type 1 PRRSV (Van Gorp 2008; Karniychuk and Nauwynck 2009). 
However, some of the more recent studies in the transgenic pigs (Prather 2013) confirmed that 
intact CD169 receptor is not required for the productive type 2 PRRSV infection. The 
importance of CD163 rather than CD169 for type 2 PRRSV viral replication was corroborated in 
pigs with an edited (non-functional) CD163 where viral replication did not occur (Whitworth 
2016). As our results suggest, CD163+ macrophages play a potentially important  role in PRRSV 
transmission across the MFI and possibly in viral propagation in the fetus thereafter. More 
research is clearly needed to determine the exact role of CD163+ placental macrophages, if they 
are also relevant for other reproductive pathogens in pigs and other animals (including humans), 
and the potential effects of CD163-/- gene editing in a pregnant animal. 
Since the PRRSV antigen has been occasionally detected in the uterine epithelial cells of 
the areolae and considering active role of the areolae in the nourishment of the fetus, we also 
evaluated the potential association of the numbers of cathepsin positive placental areolae and 
PRRSV load in the fetus. However, numbers of areolae were not significantly associated with 
PRRSV load in the fetal thymus.  
PRRSV IHC studies on the uterine tissue with fully attached fetal chorioallantois have 
been rarely reported in the past. In the present study, the presence of the PRRS virus antigen in 
uterine tissues and fetal placentae was infrequent and rarely localized in the inflammatory cells 
of the lamina propria. This unexpected finding could be due to the time point used for the 
collection of samples which at 21 DPI was past peak. Previous experiments also confirmed lesser 
numbers of type 1 PRRSV immunopositive cells in the endometrium of the sows euthanized at 
20 DPI than in those euthanized at 10 DPI (Karniychuk 2011; Karniychuk and Nauwynck 2013). 
Therefore, using IHC for detection of PRRSV antigen in the MFI is optimal in the early time 
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points of infection, but in our study other experimental activities necessitated collection at 21 
DPI. On the other hand, the PRRSV replication in the fetal lymphoid organs can continue and 
persist after birth (Rowland 2003). 
The largest numbers of cells staining with PRRSV antigen in the cytoplasm were found at 
the MFI resembling histiocytes, and to a lesser degree but surprising, in uterine epithelial cells 
and the rare fetal trophoblastic cells. PRRSV immunopositivity of uterine and trophoblastic 
epithelial cells along with occasional moderate PRRSV immunostaining of the glandular 
epithelium of the uterine glands were novel findings in this study. PRRSV infection of nasal, 
bronchiolar and alveolar epithelium has been reported before, but the mechanism of the PRRS 
virus infection of these cell types remains unexplained (Rossow 1996a; Thanawongnuwech 
1997a; Rossow 1998). Nevertheless, it has been confirmed that some epithelial cells such as St-
Jude porcine lung cells are susceptible to in vitro PRRSV infection due to the expression of 
receptor CD151 (Provost 2012). CD151 receptor has been also implicated in PRRSV infection of 
porcine endometrial endothelial cells, where it is believed to act as alternative receptor along 
with CD169 (Feng 2013). Additionally, syndecan-4, which is heparan sulfate proteoglycan, is 
confirmed to be required in the PRRSV attachment to MARC-145 cells (Wang 2016). Heparan 
sulfate proteoglycans are present on the epithelial and endothelial cells and are confirmed to bind 
to M and N proteins of the PRRSV (Delputte 2002). Another important finding from our PRRSV 
immunohistochemical analysis was the detection of PRRSV antigen in the smaller numbers of 
macrophage-looking cells present in the fetal chorioallantois in the proximity of MFI suggesting 
potential cell-associated virus spread from the endometrium to the fetal membranes. 
In summary, the results of this study have confirmed significant increases in the numbers 
of PRRSV, CD163+ and CD169+ cells at the MFI during late gestation, type 2 PRRSV infection 
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in pregnant gilts. The relationship between numbers of CD163+ cells in the endometrium and 
fetal placenta, and PRRSV viral load in the fetal thymus confirmed by this study indicates the 
essential role of CD163 expressing cells in the endometrium and fetal placenta, which provides 
additional evidence of their potential role in the mechanism of transplacental transmission of 
type 2 PRRSV during late gestation. 
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Table 4.1. Association of CD163 positive cells in the endometrium and placenta and PRRSV 
RNA concentration in fetal thymus*.  
PRRS RNA 
concentration in fetal 
thymus count† 
Coefficient 
(SE) 
95% CI P values 
Continuous model (relationship of cell numbers to PRRSV concentration in 
fetal thymus) 
 
Numbers of CD163 
positive cells per 1mm2 of 
endometrium 
 
 
0.004a 
(0.002) 
 
0.0009, 0.007 
 
0.011 
 
Numbers of CD163 
positive cells per 1mm2 of 
fetal placenta 
 
 
-0.002b 
(0.001) 
 
-0.003, -
0.0006 
 
0.005 
Inflated (logit) model‡ (relationship of cell numbers to likelihood of PRRSV 
concentration in fetal thymus being equal to zero (PRSV negative) 
 
Numbers of CD163 
positive cells per 1mm2 of 
endometrium 
 
 
-0.044c 
(0.012) 
 
-0.067, -0.021 
 
<0.001 
 
Numbers of CD163 
positive cells per 1mm2 of 
fetal placenta 
 
 
0.006d 
(0.003) 
 
0.0004, 0.011 
 
0.033 
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* Results of zero-inflated Poisson regression model. 
†Based on the distribution of data, a count model was used after categorizing PRRSV RNA 
concentration into nine 1-log10 replicates, from 0 to 9 log10 copies/mg.  
‡ The logit portion of the model predicts the odds of a fetus being negative (PRRSV RNA 
concentration = 0) from the population of fetuses from infected and negative control gilts. 
a For each one unit increase in the numbers of CD163 positive cells/mm in endometrium, 
PRRSV RNA concentration in fetal thymus increases by 0.004 log10 copies/mg.  
b For each one unit increase in the numbers of CD163 positive cells/mm in fetal placenta PRRSV 
RNA concentration in the fetal thymus decreases by 0.002 log10 copies/mg. 
c For each one unit change in the numbers of CD163 positive cells/mm in endometrium the odds 
of PRRSV RNA concentration in fetal thymus being equal to 0 (zero) decreases 1.045 times (e-
0.044). 
d For each one unit change in the numbers of CD163 positive cells/mm in fetal placenta the odds 
of PRRSV RNA concentration in the fetal thymus being equal to 0 (zero) increases 1.006 times 
(e0.006).  
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Figure 4.1. IHC for PRRSV, CD163, CD169, and cathepsin in the PRRSV-infected uterine-fetal 
placental tissues.  
A Strong immunopositive staining for PRRSV of uterine epithelial cells (arrow) of areola from 
PRRSV-infected pregnant gilt. IHC for SDOW17, bar = 200 μm: Figures 4.1A, and E. B PRRSV 
positive immunostained macrophage-like cell (arrow) in the endometrium of PRRSV-infected 
pregnant gilt. IHC for SDOW17, bar = 100 μm: Figures 4.1B, C, and D. C Strong cytoplasmic 
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immunopositive staining for CD163 of macrophages (arrows) in the chorioallantois of PRRSV-
infected pregnant gilt. IHC for CD163. D Increased numbers of CD163 macrophages in highly 
inflamed areas (arrows) in the lamina propria of endometrium from uterus of PRRSV-infected 
pregnant gilt. IHC for CD163. E Positive CD169 cells (arrowheads) in the lamina propria of 
endometrium from the uterus of PRRSV-infected pregnant gilt. IHC for CD169. F Cathepsin 
immunopositive stained areola (asterisk) at the uterus-fetal placenta interface from PRRSV-
infected pregnant gilt. IHC for Cathepsin, bar = 500 μm. 
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Figure 4.2. Mean numbers of PRRSV, CD163, and CD169 positive cells per 1 mm2 of 
endometrium and placenta.  
A Mean numbers of PRRSV (SDOW17) positive cells per 1 mm2 of the endometrium and fetal 
placenta. B Mean numbers of CD163 positive cells per 1 mm2 of the endometrium and fetal 
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placenta. C Mean numbers of CD169 positive cells per 1 mm2 of the endometrium and fetal 
placenta. Superscript letters (a, b, c or d, e, f) indicate significant differences (P < 0.05) between 
PRRSV viral load groups. Error bars represent standard error. 
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Figure 4.3. Relationship between PRRSV RNA concentration in fetal thymus and the ratio of 
CD163+endo:CD163
+
plc.  
PRRSV RNA concentration in fetal thymus groups are indicated by 3 coloured lines: negative 
(green), low (blue; 0 < log10 copies per mg < 5) and high (red; > 5 log10 copies per mg). Results 
indicate that increased ratio of CD163+endo:CD163
+
plc is associated with decreased probability of 
a fetus being in the negative and low thymic PRRSV load groups and increased probability of 
being in the high PRRSV load group. Single level proportional odds model. 
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Figure 4.4 Relationship between ratio of CD163+endo:CD163
+
plc and PRRSV RNA concentration 
in fetal thymus.  
Scatter plot of ratio of numbers of CD163+ cells in the endometrium and CD163+cells in fetal 
placenta (Y axis), and PRRSV RNA concentration (log10 copies/mg) in fetal thymus (X-axis). 
Each dot represents one fetus. Results indicate that PRRSV RNA concentration in fetal thymus is 
positively associated with ratio of CD163+endo:CD163+plc (all fetuses with high endo:plc ratios 
(>0.4) had high viral load). 
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5 Vasculitis, endometrial inflammation and cell death at the maternal-fetal interface 
during type 2 porcine reproductive and respiratory syndrome virus infection 
 
In chapter 4, we have confirmed significant increase in the numbers of PRRSV, CD163+ and 
CD169+cells at the MFI during late gestation, type 2 PRRSV infection in pregnant gilts. This 
chapter presents a further investigation of pathogenesis of fetal by assessing the numbers of 
apoptotic cells at the MFI, and evaluating their potential relationship with PRRSV viral load in 
the MFI and fetal thymus, severity of microscopic lesions in the MFI and fetal preservation 
status.  
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5.1 Abstract 
The pathogenesis of fetal death associated with porcine reproductive and respiratory virus 
(PRRSV) is hypothesized to be a consequence of trans-placental PRRSV infection causing 
severe lesions at the maternal-fetal interface. The objectives of this study were to determine 
associations between apoptosis, PRRSV load, PRRSV-induced microscopic lesions at the 
maternal-fetal interface and fetal preservation status in order to elucidate mechanisms of fetal 
demise. A total of 114 PRRSV-naïve, high-health pregnant gilts were inoculated with PRRSV on 
gestation day 85±1 with euthanasia 21 days later; 19 sham-inoculated gilts served as controls. 
Two hundred and fifty samples of MFI were selected based on negative, low RNA, and high 
PRRSV RNA concentration (0, < or > 2.7 log10 copies/mg). TUNEL assay was used to detect 
apoptosis in the endometrium and at the MFI. PRRSV load in the maternal-fetal interface, but 
not in the fetal thymus, is significantly positively associated with the degree of apoptosis in the 
endometrium and MFI. The number of TUNEL positive cells at the MFI was also positively 
associated with the distribution (P<0.05) and severity (P<0.001) of vasculitis, but not 
endometrial inflammation severity at 21 days post infection. Increased numbers of TUNEL 
positive cells at the MFI were associated with greater odds of meconium staining of the fetus at 
21 days post infection (P<0.001). These findings suggest an important role of apoptosis in the 
pathogenesis of cell death of uterine epithelial cells and trophoblastic cells at the MFI. Moreover, 
cell death at the MFI significantly contributes to fetal demise during in utero type 2 PRRSV 
infection. 
 
Keywords: porcine reproductive and respiratory syndrome, PRRS, uterus, apoptosis, TUNEL, 
vasculitis, endometritis, placenta.  
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5.2 Introduction 
Past studies proposed that PRRSV induces microscopic, gross lesions and subsequently 
clinical disease by a variety of mechanism such as apoptosis of PRRSV infected cells, non-
infected cells (bystander cells), induction of inflammatory cytokines, induction of polyclonal B 
cell activation and reduction in bacterial phagocytosis (Miller and Fox 2004). Apoptosis has been 
extensively reported within PRRSV infected cell lines in vitro (Kim 2002). Additionally, during 
the PRRSV infection of nursing and growing pigs, apoptotic cells were found widely distributed 
in infected tissues such as lungs, testes, lymph nodes, and thymus (Sur 1998; Labarque 2003; 
Costers 2008). Several studies have investigated the role of apoptosis during PRRSV infection in 
vitro and in the postnatal form of the disease. However, only one study so far has investigated 
apoptosis in the reproductive form using type 1 PRRSV and focused exclusively on the maternal-
fetal interface (MFI) (Karniychuk 2011). Therefore, there is a need to clarify the role of 
apoptosis at the MFI during type 2 PRRSV infection and also its potential associations with 
PRRSV infection both in the MFI and the fetus, PRRSV-induced microscopic lesions in the MFI, 
and fetal preservation status in order to elucidate the pathogenesis of fetal death.  
Vasculature of the uterus and fetal placenta has an essential role in the growth and 
development of the conceptus throughout gestation (Rogers 1996). During the placental 
development endometrial and placental tissues are remodeled to achieve areas of reduced 
interhemal distance (Bazer 2009). In pigs, epitheliochorial placentation is characterized by an 
intact uterine luminal epithelium which is directly attached to fetal placental trophectoderm 
during pregnancy. Transplacental exchange of gases, micronutrients (amino acids, glucose) and 
macromolecules (proteins, hormones, cytokines and other regulatory molecules) can only be 
accomplished by maternal hematotrophic and histotrophic nourishment of the fetus (Bazer 2009). 
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Hematotroph is the source of nutrition from maternal blood provided by the capillary bed in the 
endometrial invaginations in close proximity to uterine luminal epithelial cells (Enders and 
Blankenship 1999). Histotroph is another source of nutrition in pig placentation that is provided 
through secretions of uterine epithelia into the dome-shaped structures over the openings of 
uterine glands called areolae (Bazer and Johnson 2014).  
Maternal vascular complications in the human uterus and placenta have been associated 
with preterm delivery, premature rupture of placental membranes and spontaneous preterm labor 
(Kelly 2009). Additionally, it has been extensively reported that significant intrauterine 
inflammation (endometritis) is highly associated with the preterm and abnormal term labor 
(Kemp 2014). Subsequently inflammatory changes in fetal tissues (chorioamnionitis) were 
negatively related to gestational age of the fetus at delivery (Yoon 2000). Cell death (apoptosis) 
at the human maternal-fetal interface is the one of the most important underlying mechanisms of 
infection-associated rupture of human fetal membranes in reproductive failures (Fortunato 2000). 
Porcine reproductive and respiratory syndrome virus (PRRSV), together with other 
members of the virus family Arteriviridae, are known to cause a systemic necrotizing vasculitis 
affecting predominately small caliber blood vessels (Dal Canto and Virgin Iv 2000) and PRRSV-
induced vasculitis can vary in distribution and severity (Rossow 1995). Initial reports of PRRSV-
induced vasculitis in weaned and feeder pigs described it as severe, necrotizing and 
leukocytoclastic (Thibault 1998). In infected gnotobiotic and pathogen-free pigs between 3 and 
21 days post inoculation, PRRSV was shown to affect numerous arterioles and veins, and cause 
lymphohistiocytic arteritis in the thoracic aorta (Rossow 1995; Cooper 1997). 
PRRSV infection during gestation induces pathological lesions in the reproductive tract 
consisting of variable degrees of lymphoplasmacytic and histiocytic endometritis, perivascular 
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cuffing, lymphoplasmacytic segmental vasculitis, and occasionally marked microseparations 
between endometrial epithelium and placental trophoblasts (Rossow 1996b). Results from a 
recent study using a large number of PRRSV-infected uterine tissues 21 days post-infection 
(DPI) confirmed that severe inflammation in endometrial lamina propria and vasculature at the 
maternal-fetal interface (MFI) was the most frequent and consistent histopathological lesion in 
type 2 PRRSV infected pregnant gilts, and was markedly more frequent than any fetal lesion 
(Novakovic 2016a). Although cell death (apoptosis) was confirmed to be significantly increased 
at the MFI in the type 1 PRRSV-infected pregnant sows (Karniychuk 2011), it is still unclear 
whether the type 2 PRRSV induces cells death by same mechanism, or if other potential 
mechanisms are involved in the pathogenesis of reproductive failure. Thus, a mechanism has 
been proposed that in addition to PRRSV mediated apoptosis, other pathogenic mechanisms such 
as PRRSV-induced endometrial infection and/or vasculitis with subsequent vascular dysfunction 
and hypoperfusion may compromise the fragile maternal-fetal barrier and contribute to the cell 
death at the MFI and associated placental detachment from the uterus.  
The first objective of the present study was designed to evaluate the numbers TUNEL 
positive cells in the endometrium and MFI, and to test if the numbers of apoptotic cells differed 
between groups selected on the basis of PRRSV viral load (negative, low, high) in the MFI. The 
second objective was to evaluate the potential relationships between the numbers of TUNEL 
positive cells at MFI, PRRSV load at the MFI and severity of histopathological lesions affecting 
endometrium and related vasculature. Finally this study also examined the relationship between 
the apoptosis at MFI, PRRSV viral load in the fetal thymus and the preservation status of the 
corresponding fetus.  
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5.3 Material and Methods 
5.3.1 Experimental design 
The animal use protocol was reviewed and approved by the Animal Research Ethics 
Board (AREB) at the University of Saskatchewan and followed the principles established by the 
Canadian Council on Animal Care (permit #20110102). The experimental protocol for this study 
has been described in detail previously (Ladinig 2014d). Briefly, on 85±1 gestation day, 114 
PRRSV-naïve pregnant gilts were intramuscularly and intranasally inoculated with PRRSV (105 
TCID50 total dose, NVSL 97–7895, GenBank Accession No. AF325691) and 19 negative 
control pregnant gilts were sham inoculated with minimum essential medium. At 21 DPI, dams 
and their litters were humanely euthanized for necropsy examination. The reproductive tract was 
removed intact and cut opened from the tip of the horns. Each fetus was removed along with its 
umbilical cord, placenta and a portion of the uterus adjacent to the umbilical stump. The 
preservation status of each live fetus was assessed as previously described (Ladinig 2014d) based 
on the external gross appearance of its skin and umbilical cord as: viable (VIA; normal, white to 
purple skin with visible hair and regular umbilical cord), and meconium-stained (MEC; skin 
covered with inspissated, brownish amniotic fluid and regular umbilical cord with edema). All 
dead fetuses (partially decomposed to autolyzed) were excluded from this study since the MFI 
was compromised. Samples of MFI tissue (uterine with adherent placental layers) collected 4 cm 
from the umbilical attachment of each corresponding live fetus were analyzed by in-house RT-
qPCR analysis to determine PRRSV RNA concentration (log10 copies/mg) as previously 
described (Ladinig 2014d).  
From a total of 1452 infected and 231 negative control fetuses, only 679 MFI met the 
criteria of size ( 1 cm) and fully attached fetal placenta for microscopic lesion grading of 
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inflammation and vasculitis (Novakovic 2016a). A subset of 250 MFI samples was selected 
based on the PRRSV RNA concentration in the MFI. The three groups were negative (50 
samples from PRRSV non-infected pregnant gilts, PRRSV RNA not detected), low (100 samples 
from PRRSV-infected pregnant gilts, PRRSV RNA concentration less than 2.7 log10 copies per 
mg MFI), and high (100 samples from PRRSV-infected pregnant gilts, PRRSV RNA 
concentration greater than 2.7 log10 copies per mg MFI). The low and high viral samples of MFI 
corresponding to individual fetus were matched pairs from 61 PRRSV infected gilts (one pair 
from 24 gilts and two pairs from 38 gilts). Fifty MFI samples corresponding to different fetuses 
were selected from six negative control gilts (9 MFI samples from 5 gilts, 5 MFI samples from 1 
gilt). 
5.3.2 TUNEL assay 
The detection of DNA fragmentation due to apoptosis was performed using Terminal 
deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay as previously 
described at room temperature (Al-Dissi 2007). Briefly, after deparaffinization and rehydration 
of 5 m microsections of FFPE MFI tissue, protein digestion was done using Proteinase K 
solution (Dako, Carpinteria, CA) for 15 min. Endogenous peroxidase activity was blocked using 
3% hydrogen peroxide for 5 min. Equilibration buffer provided with the ApopTag Plus 
Peroxidase In Situ Apoptosis Detection Kit (Millipore, Etobicoke, Ontario) was immediately 
applied for 10 sec at room temperature, followed by terminal deoxynucleotidyl transferase (TdT) 
enzyme at 37°C for 1 hour in a humidity chamber. The slides were washed with stop/wash buffer 
for 15 sec and incubated for 10 min. After that, they were washed three times with phosphate 
buffered saline with tween20 (Fisher Scientific, Markham, Ontario) for 1 min and incubated with 
the anti-digoxigenin conjugate for 30 min. The signal was revealed using 3-Amino-9-
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Ethylcarbazole (AEC) chromogen (Dako) for 15 min and sections were counterstained with 
Mayer’s hematoxylin (Fisher Scientific) and cover slipped. 
5.3.3 Histopathology and grading schemes 
Microsections of formalin-fixed paraffin embedded (FFPE) MFI tissue stained with 
hematoxylin and eosin were used for histopathological lesion scoring of endometrial 
inflammation, distribution and severity of the vasculitis by pathologists (SD, AA, and PN) 
blinded to PRRSV RNA concentration results (Novakovic 2016a). Endometritis was assessed for 
the total area of tissue on the slide at 200X magnification and defined as normal (grade 0) if there 
were very rare inflammatory cells present. For minimal (grade 1), mild (grade 2), moderate 
(grade 3) and severe (grade 4) the percent of total tissue containing inflammatory cells was 
<10%, 10-25%, 25-50% and >50%, respectively (Novakovic 2016a). Additionally, assessment of 
the inflammation within the lamina propria of the endometrium was performed by counting the 
total number of inflammatory cells present in 9 random grid boxes at 600X field magnification 
which was equivalent to 0.05 mm2 area size per each microscopic slide (Novakovic 2016a). 
Vasculitis was scored based on the presence of inflammatory cells in the blood vessel 
wall with concomitant vacuolar degeneration and/or necrosis of the cells in the blood vessel wall 
layers (intima, media, and adventitia) as previously described (Novakovic 2016a). Briefly, 
vasculitis severity was scored by randomly selecting three 200X microscopic fields of 
endometrium per uterine tissue section in which three blood vessels were scored at 400X 
magnification as: grade 1 = only mild inflammation in wall; grade 2 = moderate inflammation in 
wall with vacuolation and splitting of smooth muscles or necrosis of wall layers; grade 3 = 
severe inflammation in wall with degeneration and necrosis in the blood vessel wall layers. 
Vasculitis distribution was scored using the percent of vessels affected by vasculitis within a 
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random 200X field as follows: grade 0 = none; grade 1 = <30%; grade 2 = 30-70; and grade 3 = 
>70% (Novakovic 2016a). 
5.3.4 Image Analysis 
Quantitative analysis of TUNEL staining was performed using an Image-Pro Plus, 
version 7 software (Media Cybernetics, Inc., Rockville, MD, USA) as previously described 
(Novakovic 2016b). Briefly, ten microscopic fields of the endometrium, captured using a 20X 
microscope objective lens, each representing 1 mm2 area (10 mm2 total/slide) were randomly 
selected from each image of the uterine-placental tissue. Multiple polygonal fields (total area size 
of 3-4 mm2) were randomly selected at the MFI (uterine and fetal placenta interdigitation area). 
Inside those selected fields, total numbers of TUNEL positive cells were manually counted and 
averaged per 1 mm2 area size for the statistical analyses. 
5.3.5 Statistical Analysis 
To determine if numbers of TUNEL positive cells in the endometrium and MFI differed 
among PRRS viral load groups (negative, low, high), separate two-level, linear mixed-effects 
regression models were developed controlling for litter of origin (gilt identification) as a random 
effect with Stata 13 (StataCorp LP, TX, USA). For these models, TUNEL positive cells in the 
endometrium and MFI were zero-skewness log (lnskew0) transformed to ensure that model 
assumptions of linearity and homogeneity were not violated. The relationship between numbers 
of TUNEL positive cells at the MFI (outcome variable) and potential endometrial inflammation 
and/or vasculitis predictors was also assessed using two-level, linear mixed-effects regression 
models. Firstly, five non-correlated, biologically plausible potential predictor variables related to 
the severity and distribution of vasculitis, endometrial inflammation severity, and viral load were 
confirmed to be unconditionally associated with the number of TUNEL positive cells (P<0.001 
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for all). All five variables were subsequently placed in a full model, and a backward, stepwise 
elimination performed to a parsimonious final model. In all models, the outcome variable 
(number of TUNEL positive cells) was natural logarithm transformed to avoid violation of the 
normality and homogeneity model assumptions. Fisher's exact test was used to compare 
histological scores of endometrial inflammation, distribution, and severity of vasculitis between 
PRRSV viral load groups.  
Finally, a multilevel mixed-effects negative binomial model was used to determine 
potential relationships between PRRS viral loads fetal thymus, and the numbers of TUNEL 
positive (apoptotic) cells at the MFI. Generalized estimating equations (GEE) accounting for gilt 
of origin (family-binomial, link-logit, correlation-exchangeable) were used to determine if the 
TUNEL positive cell count at the MFI was related to the odds of a fetus being MEC (versus 
VIA). Firstly, a model including 200 PRRSV-infected fetuses (26 MEC, 174 VIA) was run. 
Given the small number of MEC (n=26) relative to VIA (n=174) fetuses in this initial model, a 
series of smaller, balanced GEE models were developed in which the 26 MEC were matched 
with 26 randomly selected VIA fetuses. Six balanced GEEs were run, each using a different set 
of 26 randomly selected VIA fetuses; 156 fetuses in total or 90% of the VIA population.  The 
coefficients, SE, P values were compared across all models to ensure consistency and are 
reported below. 
5.4 Results 
5.4.1  Distribution of TUNEL staining in the maternal-fetal interface 
TUNEL positive (apoptotic) cells were variably distributed throughout the MFI, but 
primarily in the endometrial-placental junctional areas. TUNEL positive cells at the maternal-
fetal interface ranged from focal areas involving single cell apoptosis of trophoblast on the fetal 
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side of placenta, and uterine epithelium on the maternal side (Figure 5.1A) to multifocal areas of 
multiple cell apoptosis that were clearly associated with microseparations (Figure 5.1B). In rare 
instances, more severe separation of the placenta from the uterine epithelium was evident. Single 
cell apoptosis was also randomly distributed in the endometrium, affecting mostly mild to 
moderate numbers of inflammatory cells; predominantly lymphocytes. Occasionally individual 
cells of the uterine glandular epithelium were affected as well.  
Analyzed in the subset of 120 out of 250 samples of uterine tissue with fetal placenta, numbers 
of TUNEL positive (apoptotic) cells in the endometrium and fetal placenta were both positively 
associated with PRRS viral load groups (P<0.001, P<0.05, respectively). The number of TUNEL 
positive (apoptotic) cells was greater in the high viral load compared to low viral load group, in 
both the endometrium and fetal placenta. While also detected in the MFI of negative control 
gilts, cell counts were markedly lower in both endometrium and fetal placenta (Figure 5.2) 
compared to infected gilts. 
5.4.2  Relationship of apoptotic cell counts at MFI to severity of microscopic lesions 
The most frequent and consistent microscopic finding was lymphohistiocytic 
endometritis which was characterized by the presence of large numbers of lymphocytes mixed 
with moderate numbers of histiocytes and lesser numbers of plasma cells infiltrating lamina 
propria, uterine glands and uterine interdigitation areas (Figure 5.3). In the most severely 
inflamed areas, uterine glands lesions were characterized by attenuation and marked loss of the 
columnar glandular epithelium (necrosis), and the presence of infiltrates of large numbers of 
vacuolated macrophages in their lumina (histiocytic adenitis) (Figure 5.4). Vasculitis in the 
endometrium was multifocal to occasionally diffuse, primarily lymphocytic and to a lesser 
degree lymphohistiocytic affecting typically small to medium-sized blood vessels (Figure 5.5). 
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Both arteries and veins were affected without apparent predilection (arteritis and phlebitis). 
Occasionally vasculitis was observed in basal arteries that supply basal portion of the 
endometrium, which consisted of marked lymphocytic infiltration of the tunica intima 
(endarteritis) (Figure 5.6). Medium arteries were also affected by variable degrees of 
lymphohistiocytic arteritis accompanied by edema in the tunica intima and cytoplasmic 
vacuolation (degeneration), nuclear pyknosis and karyorrhexis of tunica media myocytes 
(necrosis). The presence of a severe lymphohistiocytic inflammation was also a frequent finding 
in the stroma of the maternal-fetal interdigitation areas (Figure 5.7). These same areas also 
exhibited strong TUNEL positive staining affecting both uterine epithelial cells and 
trophectoderm cells of the chorioallantois (Figure 5.8).  
Among the 200 PRRSV-infected uterine tissue sections with fully attached fetal placenta 
examined microscopically, there were no significant differences in endometrial inflammation 
scores between low and high PRRS virus load groups (Figure 5.9). Grade 3 endometrial 
inflammation was the most prevalent histological severity score; present in 76% (152/200) of 
PRRSV-infected samples. The vasculitis severity and vasculitis distribution scores did not differ 
between low and high PRRS viral load groups (Figures 5.10 and 5.11). Grade 1 vasculitis 
distribution (66.5%, 133/200) and vasculitis severity (62%, 124/200) were the most prevalent 
scores among PRRSV-infected samples.  
The variables unconditionally associated with the number of TUNEL positive cells at the 
MFI included: vasculitis distribution and severity score, endometrial inflammation scores, the 
total number of inflammatory cells in the endometrium, and viral load group. Of these, only 
distribution and severity of vasculitis, and PRRS viral load at the MFI were confirmed to be 
significantly associated with the number of TUNEL positive cells. Distribution of vasculitis 
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(coef. 0.27 ±0.1, 95% CI: 0.075, 0.46; P=0.007) and vasculitis severity score (coef. 0.29 ±0.08, 
95% CI: 0.13, 0.45; P<0.001) were both positively related to numbers of TUNEL positive cells 
at the MFI. Also, the numbers of TUNEL positive cells at the MFI were significantly higher in 
the low PRRSV load group than in the negative group (coef. 0.885 ±0.16, 95% CI: 0.57, 1.20; 
P<0.001), and in the high PRRS viral load group compared to the low PRRS viral load group 
(coef. 0.42 ±0.09, 95% CI: 0.25, 0.6; P<0.001). 
5.4.3  Relationship of apoptotic cell counts at MFI to PRRSV load in the fetal thymus and 
fetal preservation status 
In order to understand the association between the severity of apoptosis in fetal placenta 
and viral load in the MFI and fetal thymus, we have analyzed the subset of 120 out of 250 
samples of uterine tissue with fetal placenta. A two-level negative binomial model was 
developed and after a backwards-stepwise elimination, only viral load in the MFI (not in fetal 
thymus) was significantly associated with numbers of TUNEL positive (apoptotic) cells in fetal 
placenta (P<0.001). The number of TUNEL positive (apoptotic) cells in the fetal placenta 
increased 0.24 ±0.03 (95% CI: 0.18, 0.29) for each 1 log10 increase in PRRSV RNA 
concentration (copies/mg) in MFI. These results suggest a direct link between viral load at the 
MFI and apoptosis, which is independent from the degree of viral replication in the fetus.  
For the relationship between fetal preservation status and TUNEL positive cells count at 
the MFI, all GEE models result were consistent in confirming that an increase in TUNEL 
positive cell count at the MFI significantly increased the odds (1.06 to 1.15, depending on the 
model) of a fetus being meconium stained compared to being viable (Table 5.1). 
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5.5 Discussion 
A better understanding of the pathological processes at the MFI during type 2 PRRSV 
infection is needed to understand the pathogenesis of PRRSV-induced fetal death. In the related 
study we have confirmed that type 2 PRRSV infection causes significant microscopic lesions in 
the uterus and fetal placenta (Novakovic 2016a). The goal of this study was to evaluate the 
associations between the numbers of apoptotic cells in the endometrium and fetal placenta, and 
PRRSV viral load in the MFI and fetal thymus, microscopic lesions and fetal preservation status. 
The TUNEL analyses undertaken in the present study confirmed a significant increase in 
numbers of apoptotic cells in uterine tissue and fetal placenta and their positive association with 
PRRS viral load in the MFI. Although the apoptosis was very prominent feature in the MFI, it 
appears that it affects morphologically different cell types. In the lamina propria of the 
endometrium, the majority of the cells undergoing apoptosis were inflammatory cells; mainly 
lymphocytes. Since lymphocytes have not been reported as PRRSV susceptible cells, and in this 
study few PRRSV antigen-positive cells were present in the lamina propria, it is possible that 
significant apoptosis of individual lymphocytes may be the indirect effect of PRRSV replication 
in the susceptible cells (Sirinarumitr 1998) causing secretion of pro-apoptotic cytokines, e.g. 
TNFα secreted by macrophages (Elmore 2007).  
On the other hand, the largest numbers of apoptotic cells at maternal-fetal junction 
comprised of fetal trophoblastic epithelial cells followed by uterine epithelial cells. This finding, 
consistently present throughout all MFI samples obtained from PRRSV infected gilts, and rare in 
negative control gilts, was in agreement with previously published results (Karniychuk 2011). In 
addition, apoptosis was frequently observed closely associated with areas of detachment of the 
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chorioallantois from uterine epithelium, and could potentially be indicative of the mechanism of 
placental separation.  
Analysis of PRRSV infection in the statistical model confirmed that only PRRS viral load 
in the MFI, and not in the fetus, was significantly associated with presence of apoptosis in the 
fetal chorioallantois. This information is important for the understanding of the pathogenesis of 
PRRSV induced fetal death, because it suggests that PRRSV present in the MFI has influence on 
the occurrence of cell death in the fetal placenta. Hence, increased apoptosis in the fetal placenta 
could potentially compromise the maternal-fetal barrier causing subsequent detachment of the 
fetal placenta from the uterus, and along with other factors such as PRRSV infection of the fetus 
(Ladinig 2015a) and fetal lesions and umbilical lesions (Novakovic 2016a) contribute to fetal 
compromise.  
Although PRRS virus can induce cell death in PRRSV-permissive and bystander cells by 
apoptosis (Miller and Fox 2004), it is not clear whether this is the only pathogenic mechanism 
associated with severe detachment of chorioallantois from the uterus during type 2 PRRSV 
infection. Therefore, the additional hypothesis being tested in this study was that MFI apoptosis 
was also mediated through endometritis, metritis, and vasculitis underlying the MFI, leading to 
vascular dysfunction and consequently fetal placental damage. Also examined were the 
associations between type 2 PRRSV-induced uterine lesions and viral load, and the occurrence of 
cell death at the MFI of the pregnant gilts, as well as the relationship between fetal preservation 
status and cell death at the MFI. 
We found significant lesions of inflammation in the endometrium at 21 DPI. Endometrial 
lesions consisted of lymphohistiocytic inflammation in the lamina propria, necrosis of uterine 
glandular epithelium with lymphocytic and lymphohistiocytic adenitis, and variable degrees of 
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inflammation affecting the maternal-fetal chorionic interdigitation areas. Based on the nature of 
inflammatory cell infiltrate in the endometrium, we can conclude that innate immune system 
plays important role in the defense against PRRSV infection at MFI at 21 DPI. Local innate 
immunity at the MFI is essential for the development and immunoprotection of human fetus 
(Kemp 2014). A significant release of pro-inflammatory cytokines associated with the cellular 
innate immune response is characterized by upregulation of the IL-1β, tumor necrosis factor 
alpha (TNFα) and downregulation of placental interleukin 10 (IL-10). TNFα is also pro-
apoptotic cytokine and IL10 has been proven to be involved in pregnancy-associated disorders 
(Murphy 2009). Although in the present study endometrium exhibited a robust inflammatory 
response, no association with numbers of apoptotic cell at the MFI has been found during type 2 
PRRSV infection of gilts in the third trimester of gestation. It is clear, however, that in future 
work, cytokine expression within the endometrium needs to be measured to examine this innate 
response.  
Vascular lesions were characterized by lymphocytic and lymphohistiocytic arteritis and 
phlebitis, affecting primarily microcirculation, and occasionally medium caliber arteries with 
inflammation of tunica intima (endarteritis). Intimal arterial inflammation with evidence of 
reactive and degenerated endothelial cells is strong indication of endothelial damage (Maxie and 
Robinson 2007). This finding is suggestive of potential endothelial cell involvement in the virus 
transmission from the blood stream into the stromal tissue during PRRSV viremia. Previous 
studies reported that PRRSV antigen can be occasionally detected in the endothelial cell (Halbur 
1995), although the exact mechanism of PRRSV entry in this cell type is still not explained. 
However, recent study confirmed that porcine endometrial endothelial (PEE) cells derived from 
the primary endothelial cells originating from the uterine microcirculation are susceptible to 
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PRRSV infection in vitro (Feng 2013). PEE cells are sialoadhesin (CD169) and CD151 positive 
and CD163 negative, suggesting that these two receptors may act as possible alternatives for 
PRRSV attachment in some cells (Provost 2012). In this study, we found that some endothelial 
cell of the inflamed arteries have strong TUNEL positivity, but detection of PRRSV-specific 
SDOW17 antigen in these same sites could not be confirmed by immunohistochemistry in our 
related study (Novakovic 2016b). Inflammation of medium caliber arteries was also occasionally 
characterized by vacuolation of the cytoplasm (degeneration), pyknosis, and karyorrhexis of the 
nuclei of the smooth myocytes (necrosis) of the tunica media. Rarely tunica adventitia was 
affected by inflammation accompanied with moderate perivascular edema. Evidence of fibrinoid 
vascular necrosis, perivascular hemorrhage or thrombi were not observed in this study.  
Microcirculation of the uterus and fetal placenta demonstrated the most severe lesions of 
inflammation with frequent complete disruption of the vessel wall. According to our histological 
grading results, higher scores (grade 3 and 4) of inflammation affecting lamina propria, uterine 
glands and interdigitation areas of endometrium were more frequent compared to lower scores 
(grades 1 and 2) in type 2 PRRSV infected samples. However, no difference was found in the 
endometrial inflammation scores across PRRS viral load groups. Distribution and severity of 
vasculitis showed the predominance of lower scores in both PRRSV load groups without 
significant difference. These findings were in accordance with previous similar observations 
(Lager and Halbur 1996; Rossow 1998; Zimmerman 2012), and our previous observations 
(Novakovic 2016a) which confirmed the importance of endometrial inflammation as specific, 
reproducible lesion in the reproductive form of type 2 PRRSV infection at 21 DPI. However, 
when the histological grading scores were offered in the statistical model used to predict cell 
death at the MFI, only PRRSV load, distribution and severity of vasculitis, but not the severity of 
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endometrial inflammation, were positively related to the numbers of apoptotic cells. These 
results indicate a potential role of PRRS virus-induced vasculitis in the pathogenesis of the cell 
death at MFI rather than endometrial inflammation. Furthermore, this suggests that hematotroph, 
which plays an essential role in the development and growth of the porcine fetus, may be 
compromised. This may be one reason why fetal death appears to disproportionately affect large 
fetuses rather than small fetuses and why the body weight of surviving fetuses is decreased 
following transplacental PRRSV infection (Ladinig 2014a). Vascular dysfunctions causing 
hypoperfusion and ischemia have already been implicated in human pregnancies complicated by 
preeclampsia, placental abruption, and fetal growth restriction (Kelly 2009). Whether or not 
PRRS virus-induced vascular inflammation affecting primarily microcirculation could impair 
blood perfusion to such degree to lead to severe metabolic derangements of uterine and 
trophoblastic epithelial cells of the porcine epitheliochorial placenta will require further 
investigation in the future. Considering the results obtained in the present study, we think that, in 
addition to the PRRSV mediated apoptosis at the MFI, PRRSV induced vascular lesions may 
very well act as a supplementary pathogenic mechanism which exacerbates the deleterious 
effects on maternal-fetal barrier.  
Finally, this study confirmed a significant, positive relationship between the degree of 
cell death (apoptosis) at the MFI and meconium staining, an indicator of intrauterine stress and 
early pathologic stage of acute fetal PRRSV infection (Ladinig 2014a). More specifically, the 
odds of a fetus being meconium stained increased as did the numbers of apoptotic cells at the 
MFI. This result reveal that in addition to the PRRSV infection of the fetus (Ladinig 2015a) and 
fetal and umbilical lesions (Novakovic 2016a), apoptosis of the uterine epithelial cells and 
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trophoblastic cells at the MFI also contribute to fetal demise during in utero type 2 PRRSV 
infection.  
5.6 Conclusions 
In this experimental study of type 2 PRRSV infection of third trimester pregnant gilts, we 
confirmed a significant increase in the numbers of apoptotic cells at the MFI, significant, positive 
association between the apoptosis at the MFI and the severity and distribution of PRRSV-
induced vasculitis in the endometrium. We also determined that an increase in the numbers of 
apoptotic cells at the MFI is significantly associated with odds of fetal meconium staining. This 
research helps to advance the understanding of the pathogenesis of fetal demise in type 2 
reproductive PRRS.   
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Table 5.1 Results of Generalized estimating equations (GEE) confirming the association 
between numbers of TUNEL positive cells at MFI and the odds of a fetus being MEC (versus 
VIA).  
GEE model* No.a Coefficient 
Odds 
Ratio 
SE P values†  95% CI 
Final‡ 200 0.08 1.08 0.015 <0.001  0.051, 0.109 
1 52 0.074 1.08 0.021 <0.001  0.033, 0.115 
2 52 0.136 1.15 0.04 <0.001  0.058, 0.214 
3 52 0.093 1.10 0.026 <0.001  0.042, 0.143 
4 52 0.066 1.07 0.021 0.001  0.256, 0.106 
5 52 0.062 1.06 0.02 0.002  0.023, 0.101 
6 52 0.101 1.11 0.029 0.001  0.044, 0.159 
AVG of 6 
balanced 
GEE models 
 0.089 1.09     
 
* A model with 200 fetuses was initially run followed by six balanced GEE models including 26 
MEC fetuses and a different set of 26 randomly selected VIA fetuses. 
† Statistical significance was assigned at the P < 0.05 level. 
‡ Initial GEE model with 200 PRRSV-infected fetuses (26 MEC, 174 VIA).  
a Total number of fetuses analyzed in the model  
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Figure 5.1A-B. TUNEL assay in the uterine-fetal placental tissues from PRRSV-infected pregnant 
gilts.  
A Focal area of apoptosis (arrow) affecting both the trophoblast and uterine epithelial cells at the 
uterus-fetal placenta interface from PRRSV-infected pregnant gilt. TUNEL, bar = 100 μm. B 
Multiple apoptotic cells (arrows) closely associated with the area of microseparation between 
chorioallantois and uterus (asterisk) from. TUNEL, bar = 200 μm. 
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Figure 5.2. Mean numbers of TUNEL (apoptotic) positive cells per 1 mm2 of the endometrium 
and fetal placenta.  
Superscript letters (a, b, c or d, e, f) indicate significant differences (P < 0.05) between PRRSV viral 
load groups. Error bars represent standard error. 
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Figures 5.3-5.8. Microscopic lesions and apoptosis at MFI during type 2 PRRSV-infection, 
pregnant gilt, uterus.  
Figure 5.3. Inflammatory cell infiltrates in the lamina propria (stroma) of the endometrium, 
surrounding capillaries (arrowhead) and infiltrating uterine glands (arrow). Hematoxylin and 
eosin (HE). Figure 5.4. Uterine glands in the lamina propria have lost glandular epithelium 
(necrosis) and are dilated by infiltrates of inflammatory cells (arrow); normal uterine glands 
(arrowhead). HE. Figure 5.5. Multiple arteries in the lamina propria affected by 
lymphohistiocytic vasculitis (arrows). HE. Figure 5.6. Basal endometrial artery with clusters of 
lymphocytes infiltrating tunica intima only (endarteritis) (arrowheads). HE. Figure 5.7. Large 
numbers of inflammatory cells are infiltrating stroma, arterioles and capillaries of uterine-fetal 
placenta interdigitations (asterisk). HE. Figure 5.8. Apoptotic inflammatory cells (arrowhead) 
closely associated with uterine luminal epithelial and trophoblastic cells undergoing apoptosis in 
the area of severe separation of the chorioallantois from the uterus (arrow). TUNEL assay. 
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Figure 5.9. Histological grades for endometrial inflammation for each PRRS viral load group.  
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Figure 5.10. Histological grades for vasculitis distribution for each PRRS viral load group.  
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Figure 5.11. Histological grades for vasculitis severity for each PRRS viral load group.  
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6 General discussion 
The overall aims of the studies presented in this thesis were to improve understanding of 
the pathogenesis of PRRSV fetal infection and death during the type 2 PRRSV infection in the 
third trimester of pregnant gilts. Therefore, examination and assessment was needed on 
significant pathological lesions, potential relationships between histological lesions, numbers of 
CD163, CD169 positive PRRSV susceptible cells, areolae, PRRSV-induced apoptosis at the 
MFI, and PRRSV RNA concentration in the fetuses and MFI.  
The tissues assessed were from a large, multicenter PRRS study with the highest number 
of pregnant gilts ever used in a single trial, providing an unprecedented opportunity to examine 
large numbers of PRRSV-infected fetuses and corresponding uterus with the fetal placenta. 
Results generated by the pathological assessment of tissues from 1683 fetuses and adjacent 
uterine tissue with the fetal placenta in Chapter 3, demonstrated that the most consistent and 
prominent lesions were observed at the MFI including endometrium, vasculature, and fetal 
chorioallantois while fetal histopathological lesions were less frequent and more variable in 
severity and presentation.  
These results showed to be in agreement with previous studies (Lager and Mengeling 
1995; Rossow 1996b; Rossow 1998). The unique contribution of this study to other pathological 
studies of the reproductive form of type 2 PRRSV infection was the development of the specific 
histological grading scheme which allowed semi-quantitative assessment of the severity and 
distribution of microscopic lesions and subsequent analyses of their relationship with 
concentrations of the PRRSV in the uterine and fetal tissues. Additionally, exceptionally large 
numbers of tissue samples obtained from this experiment provided substantial statistical power to 
determine complex associations between different factors of infection. Results of the histological 
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grading revealed that 73% of uterine tissue samples exhibited moderate and 10% of samples 
severe lymphohistiocytic endometritis while one-third of the samples had severe vasculitis in 
more than 30% of blood vessels in the endometrium.  
These findings confirmed that inflammation in the uterus, fetal placenta, and endometrial 
blood vessels are major pathological characteristics of type 2 PRRSV infection at late gestation 
in pregnant gilts. Nonetheless, a “significant relationship between the concentration of PRRSV 
RNA in the maternal-fetal interface and the severity of endometrial inflammation or the 
distribution and severity of endometrial vasculitis” could not be confirmed at 21 days post 
inoculation (Novakovic, 2016a). These findings indicate that the inflammatory process at the 
maternal-fetal interface 21 DPI was most likely passed its peak and it was no longer significantly 
associated with PRRSV load in the MFI. This was also partially supported by the finding of a 
significant negative relationship between endometrial inflammation and PRRSV RNA 
concentration in fetal thymus, which may indicate that the duration of PRRSV infection in the 
porcine fetus is longer than in the uterus while the severity of endometrial inflammation starts to 
decline at 21 DPI. Therefore, the time of collection of MFI samples at 21 DPI represents one of 
the biggest limitations of this experiment. While this was done to enable the collection of other 
phenotypic data from dams and fetuses (Ladinig 2014a; Ladinig 2014b; Ladinig 2014c; Ladinig 
2014d; Ladinig 2015a), it did limit the number of MFI samples evaluated since many dead and 
autolyzed samples were excluded.  
The novel finding in this study was the “significant relationship between the distribution 
and the severity of the vasculitis in the lamina propria, and the severity of endometrial 
inflammation” (Novakovic, 2016a) which suggests that endometrial blood vessel inflammation 
determines the severity of inflammation in the uterus and plays an essential role in the 
 107 
transmission of PRRSV to the maternal-fetal interface and further to the fetus. Another novel 
finding was the positive relationship between the concentration of PRRSV at the maternal-fetal 
interface and the fetal thymus, and fetal lesions indicating that the concentration of PRRSV in 
the uterus, fetal placenta, and fetus are all related to the occurrence of fetal pathology. Although 
this finding is in contradiction with some more recent studies (Karniychuk 2011; Karniychuk and 
Nauwynck 2013), it suggests that fetal lesions are a consequence of a complex set of interactions 
of virus in fetal and maternal compartments, rather than the result of independent pathological 
processes at one or the other site. Furthermore, in this study, results confirmed that fetal 
preservation status is strongly associated with the presence of fetal and umbilical cord lesions 
indicating their important role in the pathogenesis of fetal death in type 2 in utero PRRSV 
infection.  
In the second study (presented in chapter 4), it was confirmed that type 2 PRRSV 
infection significantly increases numbers of CD163+ and CD169+ macrophages in the 
endometrium and the fetal placenta in PRRSV-infected versus non-infected pregnant gilts. In 
particular, the numbers of CD163 and CD169 positive cells in the endometrium were 
consistently different between PRRSV-infected and negative control pregnant gilts suggesting 
their role in the innate and cell-mediated immune response to PRRSV infection. The most 
interesting finding was the discovery of relatively constant numbers of CD163 positive cells in 
the fetal placenta closely associated with the maternal-fetal interface which was demonstrated by 
a lack of significant difference in numbers of CD163 positive cells in fetal placenta between 
negative control and PRRS-infected pregnant gilts. It is possible that this stable population of 
CD163 positive cells represents fetal tissue-specific macrophages, porcine analogs of human 
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Hofbauer cells, which are involved in the prevention of the vertical transmission of the 
pathogens.  
Although the numbers of CD169 positive cells were increased both in the endometrium 
and fetal placenta during the PRRSV infection, only numbers of CD163 positive macrophages in 
the endometrium and fetal placenta were significantly associated with the PRRSV infection of 
the fetus. Furthermore, the relationship between viral load in fetal thymus and the ratio of 
CD163+ cells present in endometrium and fetal placenta, revealed a positive association. In other 
words, if this ratio is high, such as in situations of increased infection pressure in the uterus and 
low placental immune surveillance in the fetal placenta, the odds of fetal thymus being PRRSV 
virus positive increased dramatically, and vice versa.  
This was an exciting novel finding which suggested a potential, but so far unknown, 
mechanism of PRRSV resistance in late gestation fetuses and warrants special attention to 
CD163 positive cells in the fetal placenta in the future studies. Particularly, in the view of the 
most recent discoveries which have confirmed that knockout pigs (CD163–/–) are resistant to 
PRRSV challenge, this new piece of information about the importance of residential population 
of fetal placental macrophages in protection against the transplacental infections has to be 
carefully considered in planning future genetic selection programs.  
The third study (presented in chapter 5) revealed that type 2 PRRSV infection increases 
significantly the numbers of cells undergoing apoptosis both in the uterine tissue and fetal 
placenta. However, the type of cells undergoing apoptosis in the endometrium and fetal placenta 
are quite different morphologically. In the lamina propria of the endometrium, the majority of 
apoptotic cells are inflammatory cells, particularly lymphocytes which may represent the indirect 
cytopathic effect of PRRSV replication in the susceptible cells, and would be less likely to have 
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a significant effect on the fetal pathology. However, the significant apoptosis in the MFI 
affecting the fetal trophoblastic epithelial cells and uterine epithelial cells was a common finding 
in the PRRSV-infected pregnant gilts and rare in negative control gilts. This degree of apoptosis 
could potentially compromise the maternal-fetal barrier and have detrimental effects on the fetus.  
Additional proof was found in the frequent presence of apoptotic cells in the areas of 
detachment of the chorioallantois from the uterus, and the significant statistical association 
between the numbers of apoptotic cells at the MFI and fetal meconium staining. Results from the 
second study also confirmed that only presence of the PRRSV virus in the uterus and fetal 
placenta, not in fetal tissues, are significantly positively associated with the extent of apoptosis in 
the fetal chorioallantois. This suggests the involvement of PRRSV in causing cell death and 
proposes that cell death at the maternal-fetal interface is a contributing factor in the pathogenesis 
of fetal death. Figures 6.1 and 6.2 schematically summarize the overall significant pathological 
factors and their relationships with PRRS viral load in the maternal-fetal interface and fetal 
thymus confirmed in our first, second and third study. 
Finally, the third study revealed that the presence of PRRSV in the uterus and fetal 
placenta, along with distribution and severity of vasculitis, are positively associated with the 
numbers of apoptotic cells at the MFI, but not the severity of inflammation in the lamina propria, 
uterine glands, and interdigitating areas. These results indicate the greater importance of the 
PRRSV-induced vasculitis than inflammation of the lamina propria, uterine glands and maternal-
fetal interdigitation areas in the pathogenesis of the cell death during the type 2 PRSSV infection 
in utero. Therefore, cell death at the MFI could be a result of the combined effects of directly 
induced and cytokine-mediated PRRSV infection, and vascular lesions causing hypoperfusion 
and hypoxia. Also, the extent of cell death at the MFI significantly increases the odds of fetal 
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meconium staining of the fetuses. Figure 6.3 schematically summarizes all the predictors of the 
odds of fetal meconium staining as indicator of fetal demise confirmed in our first and third 
study. 
In conclusion, this large-scale, multicenter, experiment with pregnant gilts challenged 
with type 2 PRRSV at third trimester of gestation enabled an unprecedented and extensive 
evaluation of fetal and uterine lesions at 21 DPI and revealed multiple factors important in the 
pathogenesis of fetal death. Studies presented in this thesis confirm type 2 PRRSV infection in 
pregnant gilts in the third trimester of gestation induces significant pathological lesions at the 
maternal-fetal interface, and that fetal and umbilical pathology together with PRRSV viral load 
in the fetus and increased cell death at the MFI contribute to fetal compromise and death. In 
terms of the other important factors of in utero PRRSV infection, this study found that only an 
increase in numbers of CD163 positive macrophages in the endometrium in concert with the 
decrease in the numbers of CD163 positive macrophages in the fetal placenta significantly 
increased the probability of PRRSV infection of the fetus.  
6.1 Limitations and future directions 
Future research work in this area has the potential to evolve into several different 
directions. One of the biggest limitations of our first study was primarily associated with the time 
of the sampling. The decision to terminate the study at 21 days post inoculation has resulted in a 
smaller number of intact MFI samples due to increased numbers of dead and autolyzed fetuses 
that could not be investigated. Since the sampling also was past the peak viral replication stage 
(typically 10-14 DPI), a 21 DPI termination also resulted in missing the acute stages of 
inflammatory reaction and pathological lesions at the maternal-fetal interface. Future studies of 
PRRSV infection of pregnant gilts must be focused on overcoming that limitation using multiple 
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and earlier termination points of the experiment. This approach may prove to be a very useful in 
increasing the numbers of viable and meconium stained fetuses, subsequently increasing the 
chances of observing more consistent fetal lesions along with immunohistochemical detection of 
PRRSV antigen in the fetus and chorioallantois, and potentially finding a greater correlation 
between pathological lesions and the PRRSV presence at the maternal-fetal interface.  
Also, future experimental approaches should be focused on the molecular analyses of the 
pro-inflammatory and pro-apoptotic cytokine profiles in the endometrium of the uterus 
separately from the fetal chorioallantois. This research work would give new insight into the 
upregulation and downregulation of inflammatory and apoptotic pathways associated with early 
type 2 PRRSV infection at the maternal-fetal interface. Another direction for the future research 
work in this area must include the analyses of the uteroplacental and fetal hypoxia as a potential 
consequence of the vascular dysfunction by investigating the hypoxia signaling pathways at the 
maternal-fetal interface and fetal tissue separately.  
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Figure 6.1. Relationship between PRRS viral load in the maternal-fetal interface and various 
significant variables of PRRSV infection.  
Direction of the arrows indicates predictor/outcome relationship, and plus sign is positive 
association.  
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Figure 6.2. Relationship between PRRS viral load in the fetal thymus and various significant 
variables of PRRSV infection.  
Direction of the arrow indicates predictor/outcome relationship, and plus/minus sign represent 
positive/negative association between variables.  
  
 114 
 
 
Figure 6.3. Relationship between fetal preservation status (meconium versus viable) and various 
predictor variables of PRRSV infection.  
MEC - meconium-stained fetuses with skin covered with inspissated, brownish amniotic fluid 
and regular umbilical cord with edema. VIA - viable fetuses with normal, white to purple skin 
with visible hair and regular umbilical cord. Direction of the arrow indicates predictor/outcome 
relationship, and plus/minus sign represent positive/negative association between variables.  
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